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ABSTRACT
METHODS FOR MAKING POLICY-RELEVANT
FORECASTS OF INFECTIOUS DISEASE INCIDENCE
MAY 2019
STEPHEN ALEXANDER LAUER
B.S., UNIVERSITY OF MARYLAND, COLLEGE PARK
M.S., UNIVERSITY OF MASSACHUSETTS, AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Nicholas G. Reich
Infectious diseases place an enormous burden on the people of the developing
world and their governments. When, where, and how to allocate resources in order
to slow the spread of a virus or deal with the aftermath of an outbreak is often the
responsibility of local public health officials. In this thesis, we develop statistical
methods for forecasting future incidence of infectious diseases and estimating the
effects of interventions designed to reduce future incidence, bearing in mind the needs
and concerns of those public health officials.
While most infectious disease forecasting models focus on short-term horizons (i.e.
weeks or months), long-term forecasts made prior to the epidemic season may be more
useful to public health officials. In Chapter 2, we make an annual forecasting model
for dengue hemorrhagic fever incidence based on early season incidence, weather, and
iv
demographics. The predictions from this forecasting model outperform a baseline
model based on the ten-year median on out-of-sample data. To our knowledge, this
model makes accurate annual forecasts earlier in the year than any other dengue model
on record.
After public health officials implement an intervention, whether a preventative
action or a response to a developing outbreak, they may want to know whether
that intervention was effective. In Chapter 3, we evaluate an effect estimation
technique, called covariate-adjusted residuals, within a causal inference framework.
This technique was originally developed for use in randomized trials, but has also been
used in observational settings in ecology. Much research in the field of causal inference
has focused on developing methods that account for confounding in non-randomized
experiments. To our knowledge, we are the first to evaluate covariate-adjusted residuals
from a causal inference perspective, and to develop an extension for use in observational
studies.
In Chapter 4, we investigate whether using forecasts can improve the efficacy of
effect estimation. In certain situations, forecasting can be used for covariate selection
and dimension reduction that improves the performance of covariate-adjusted residuals
in estimating the effect of an intervention. We used our findings to estimate whether
an intervention for Zika reduced dengue hemorrhagic fever incidence in Thailand in
2016.
v
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CHAPTER 1
INFECTIOUS DISEASE FORECASTING FOR PUBLIC
HEALTH
(The contents of this chapter are under revision for the book Population Biology of
Vector-borne Diseases, co-authored with Alexandria C. Brown and Nicholas G. Reich.)
“... diviners employ art, who, having learned the known by observation,
seek the unknown by deduction.”
– Cicero (as quoted in [123])
“We may regard the present state of the universe as the effect of its past and the
cause of its future. An intellect which at a certain moment would know all forces that
set nature in motion, and all positions of all items of which nature is composed, if
this intellect were also vast enough to submit these data to analysis, it would embrace
in a single formula the movements of the greatest bodies of the universe and those of
the tiniest atom; for such an intellect nothing would be uncertain and the future just
like the past would be present before its eyes.”
– LaPlace (1825) (as quoted in [182])
1.1 Background
1.1.1 A brief history of forecasting
The ability to foretell, or divine, future events has for millennia been seen as a valued
skill. While there are records of Babylonians attempting to predict weather patterns
as early as 4000 BCE based on climatological observations [130], early attempts at
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divination were just as likely to be driven by unscientific observation. However, in the
last 150 years, rapid technological advancements have made data-driven forecasting a
reality across a number of scientific and mathematical fields.
The science of forecasting was pushed forward especially in the second half of the
20th century by the fields of meteorology and economics, but more recently other
fields have started to build on this research. Examples include world population
projections [64, 155], political elections,[29, 69, 112], seismology[54, 25], as well as
infectious disease epidemiology [15, 115, 199, 81, 158].
Forecasting has been an active and growing area of research for over a century
(1.1), with particular acceleration observed since 1980. While research focused on
forecasting infectious diseases started in earnest in the 1990s, since 2005 the number
of articles on infectious disease forecasting has increased seven-fold, at a faster pace
than research on general forecasting during that time, which increased by a factor of 3.
In 1991, forecasting was the topic of one of every thousand published academic papers,
based on counts from the Science Citation Index and the Social Science Citation
Index, obtained from the Web of Science. In 2017, despite an overall rise in academic
publication over previous decades, over four of every thousand published papers were
about forecasting.
1.1.2 What is a forecast?
In common parlance, there is not a strong distinction between the terms ‘pre-
diction’ and ‘forecast.’ Nor does there exist a strong consensus in the biomedical,
ecological, or public health literature on the distinction. Nate Silver has suggested that
etymologically, the term forecast “implied planning under conditions of uncertainty”
in contrast to prediction, which was a more ancient idea associated with superstition
and divination [182]. In the modern scientific world, some fields, such as seismology,
use the term forecast to refer to a probabilistic statement in contrast to a prediction
2
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Figure 1.1. Publication trends from 1970 through 2016. The y-axis in each panel
shows the number of publications, according to the Web of Science, for papers with
the topic of (A) ‘forecast*’, and (B) ‘forecast*’ + any of a list of infectious diseases
taken from WHO [206]. There are 1,989 and 0 publications, respectively, that were
published prior to 1970. All counts are taken from the Science Citation Index and the
Social Science Citation Index, obtained via the Web of Science database.
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which is a “definitive and specific” statement about a future event. In other fields, the
difference in meaning is even less clearly defined, with forecasting often connoting the
prediction of a future value or feature of a time-series [40]. We note that convention
in biomedical research uses the term ‘prediction’ to refer to an individual-level clinical
outcome (e.g. risk-scores give individualized predictions of heart attack or stroke risk),
but both ‘prediction’ and ‘forecast’ are used interchangeably to refer to events or
outcomes that may impact more than one person. The term ‘forecast’ may often refer
more broadly to a trend or event observable or experienced by many individuals rather
than a local, individualized outcome. Our use of the term forecasting will take aspects
from several of these definitions. Specifically, we define a forecast as a quantitative,
probabilistic statement about the uncertainty surrounding an event, outcome, or trend
that has not yet been observed, conditional on data that has been observed.
Note that a forecasted event or outcome need not necessarily be in the future,
as events in the past that have not yet been quantitatively measured may also be
forecasted. For example, on May 1 we may have data for a particular time-series
available through April 1. We could make a “forecast” of the time-series for April 15
even though this event is in the past. This type of forecast has been referred to as a
“nowcast”, although more generally, this is a special case of a forecast.
1.1.3 Forecasting challenges that are specific to infectious disease
There are operational and statistical challenges in forecasting that are specific to
the setting of infectious disease. These challenges in and of themselves may not be
unique to the field, but taken together, they describe obstacles that forecasters face
when taking on a problem in infectious disease.
1.1.3.1 Challenge 1: Unobserved Complexity
When attempting to forecast the transmission of an infectious disease, researchers
need to account for processes on scales from micro to macro. Behaviors of and
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interactions between viruses, vectors, hosts, and the environment each play a part in
determining the spread of a disease. Fundamentally, viruses are microscopic organisms
whose interactions with their hosts (humans or vectors), competition with other
viruses, and genetic mutations determine their potential for survival, transmission,
and the severity of their induced infections. Whether biological data can be used
for forecasting population-level transmission remains to be seen (Section 1.2.3.1).
Researchers have developed mechanistic models based on biological and behavioral
principles that encode the processes by which diseases spread between humans (Section
1.2.1.1). Environmental conditions may dictate not only the life cycle of vectors, such
as Aedes mosquitoes, but also human behavior. The inclusion of climate covariates
has a mixed record for forecasting disease transmission (Section 1.2.3.2).
Therefore the key challenges for forecasting infectious disease are both in the
complexity of the biological and social models needed, but also in the available data
[133]. For forecasting weather, scientists rely on thousands of sensors across the world,
collecting continuous real-time data. These rich and highly accurate data streams are
unavailable to infectious disease researchers whose gold-standard data by and large
come from very human systems: epidemiological surveillance systems that capture
only a fraction of all cases and often are reported with substantial delays.
1.1.3.2 Challenge 2: The Forecasting Feedback Loop
Forecasts of disease incidence can encourage governments and public health orga-
nizations to intervene in order to slow transmission. If forecasts of infectious disease
are used to inform targeted interventions or risk communication strategies and the
interventions change the course of the epidemic, then the forecast itself becomes en-
meshed in the causal pathway of an outbreak. This feedback loop has been identified
as the single most important challenge separating infectious disease forecasting from
forecasting natural phenomena such as weather [133].
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In settings where forecasts will be used to inform interventions, this feedback loop
of infectious disease forecasting should be taken into account in the forecasts. Without
such accounting, if a forecast predicts an outbreak and triggers an intervention that
prevents the epidemic from taking off, then the forecast itself would be seen as wrong,
despite this being a public health victory. This implies that forecasting models should,
when in these settings, create multiple forecasts under different intervention scenarios.
Mechanistic forecasting models, that use explicit disease transmission parameters,
may be best suited for these types of forecasts, since intervention effects could be
incorporated directly as impacting these parameters.
Method development is needed in this area to address open scientific questions.
What model frameworks can best balance forecast accuracy with the ability to
incorporate multiple potential future scenarios? Can forecast models be used to assess
intervention effectiveness?
1.1.4 Definitions and basic notation
Here, we will introduce some basic mathematical notation for time-series forecasting
that we will use throughout this chapter. In many forecasting applications, including
many of those for infectious disease, the available data are often a time series of
observed values for a particular location or setting. For infectious disease applications,
these data are often a measure of incidence, such as case counts or the percentage of
all doctor visits with primary complaint about a particular disease. In the text that
follows, we will use language specific to that of spatio-temporal disease incidence data,
although much of what we describe can be applied more generally as well.
1.1.4.1 Data
We will start with a toy example and later extend the notation to more realistic
scenarios. In our example, we have a complete (i.e. no missing data) time series of
infectious disease case counts from a single location, such as a school or hospital. We
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define yt as an observed value of this incidence in time interval t from our time series
{y1, y2, y3, . . . yt, . . . , yT}. We assume that these observations are draws from random
variables Y1, Y2, Y3, . . . , Yt, . . . , YT , whose probability distributions can be thought of
as a function of t, prior values of y represented as y1:t, and other covariates xt. We
use T throughout to refer to the total number of time points in the time-series and t
to refer to a specific time point relative to which a forecast is generated.
Two important features of our observed data are frequency and scale. In our
example, incidence is recorded at regular time intervals. Furthermore, many processes,
including our infectious disease time series, have a cyclical element. We define the
frequency of a time series as the number of observations within a single cycle. For
example, if we have monthly incidence data and know that there are annual weather
patterns that influence incidence in our observed data, the frequency of our time series
would be 12 months/observations.
1.1.4.2 Targets
Targets are the as-yet-unknown features of the data that are the subject of
forecasting. In our toy example, we may want to forecast incidence at a certain future
time—but targets can be a variety of endpoints extrapolated from the observed data.
For forecasts of the time-series values itself, i.e. when a target is defined to be a past
or future value of the time-series Yt+k, we use a special nomenclature, referring to
them as ‘k-step-ahead‘ forecasts. We define Zi|t as a random variable for target i
positioned relative to time t. For example, in the infectious disease context, Zi|t could
be:
• incidence at time t, or Yt,
• incidence at time t + k either in the future or past relative to time t, or Yt+k,
where k is a positive or negative integer,
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• peak incidence within some period of time or season, or maxt(Yt) where t are
defined to be within a season,
• the time at which a peak occurs within some season, or {t′ : Yt′ = maxt(Yt)}
• a binary indicator of whether incidence at time t+k is above a specified threshold
C, or 1{Yt+k > C}.
1.1.4.3 Forecasts
A forecast, as defined in Section 1.1.2, must provide quantitative and probabilistic
information about an outcome. In the context of this notation, a forecast can be
represented as a predictive density function for a target, or fzi|t(z|y1:t, t, xt). The form
of this density function will depend on the type of variable that Z is, and it could be
derived from a known parametric distribution or specified directly. For example, if
the target is a binary outcome (e.g. whether in week 4, the observed incidence will
be above 10 cases) the density could be specified as a Bernoulli distribution with a
parameter associated with the probability of the outcome occurring. It could also be
specified directly as a probability that the incidence is >10 and the probability that
the incidence is ≤ 10. For a continuous target (e.g. the number of new cases occurring
in February), the predictive density could be represented by a Poisson distribution
with a given mean or as a vector of probabilities associated with all possible integer
values of cases.
To enable clear definitions for forecasting in real-time, forecasts must be associated
with a specific time t. This time t represents the point relative to which targets are
defined. For example, if a forecast is associated with week 45 in 2013, then a ‘-1-step-
ahead’ (read ‘minus-one-step-ahead’) forecast would be associated with incidence in
week 44 of 2013 and a ‘3-step-ahead’ forecast would be associated with week 48.
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1.1.4.4 Forecast time-scale
Another consideration for infectious disease forecasting is the forecast horizon,
the temporal range that the forecast predicts [137, 184]. Regardless of the model
type, many recent infectious disease forecasting efforts have focused on short time
scales (weeks or months) [17, 27, 63, 83, 114, 120, 142, 158, 176, 178, 189, 211]. These
studies demonstrated the importance of recent case counts and seasonality on the
immediate trajectory of infectious disease incidence. In 2015, the National Oceanic
and Atmospheric Administration (NOAA) and the Centers for Disease Control and
Prevention (CDC) hosted a competition to make within-season forecasts for longer
forecast horizons, such as annual dengue incidence, epidemic peak, and peak height, for
San Juan, Puerto Rico and Iquitos, Peru [138]. Prior to these competitions, long-term
forecasts were more commonly used for chronic disease prevalence than for non-chronic
infectious disease incidence [184].
1.2 Models used for forecasting infectious diseases
1.2.1 Mechanistic vs. Statistical: a taxonomy of forecasting models
According to Myers et al., forecasting models for infectious diseases take either
a ‘biological approach’ or a ‘statistical approach’ [137]. Others have phrased this
distinction as one of mechanistic (i.e. biological) and phenomenological (i.e. statistical)
models. A model based on disease biology can account for previously unforeseen
scenarios that are possible due to transmission dynamics, however these models often
require specification of a large number of parameters and covariates in order to make
forecasts. On the other hand, statistical forecasting models are restricted by the
assumption that future incidence will follow the patterns of incidence observed in the
past, but can be specified without full knowledge of the disease process or interactions
between members of the population. In this section, we will discuss the major modeling
methods across the biological-statistical spectrum (1.1).
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Table 1.1. Taxonomy of models and methodologies for infectious disease forecasting.
Methods for mechanistic models Methods for phenomenological models
Deterministic differential equations Generalized linear models
Stochastic differential equations - climate and/or AR terms
Chain binomial models - sinusoidal seasonality
Agent-based simulation models - penalized regression (i.e. “large p”)
Filtering approaches (Kalman, particle) ARIMA and extensions
Bayesian networks Classification and Regression Trees
TSIR methods Kernel Conditional Density Estimation
Growth models Ensemble methods
1.2.1.1 Mechanistic models
Compartmental models are the standard biological, or mechanistic, approach for
modeling infectious disease [102, 181, 111]. Kermack and McKendrick proposed the
first such model, now known as the susceptible-infectious-recovered (SIR) model, in
which members of a population transition through each compartment (susceptible
to infectious to recovered) over the course of an epidemic [105]. While this process
mimics the behavior of an outbreak, the simplest model assumes that the population
is “well mixed”, such that each individual is equally likely to encounter any other
individual. Since this is unlikely, researchers can add more compartments (e.g. adults
and children), along with contact rates between compartments, or individually model
each member of the population (i.e. agent-based modeling) [49]. Though greater
complexity requires more modeling assumptions, compartmental models have been
effective at estimating underlying infectious disease processes and the potential impact
of interventions [111, 52, 102, 160]. Recently, several papers extended compartmental
models for use in forecasting infectious disease incidence, particularly for influenza
[17, 142, 145]. Additionally, Shaman and Karspeck incorporated humidity into a SIRS
compartmental model to forecast influenza [175, 176]. And SIR models have been
used to forecast dengue outbreaks [209].
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1.2.1.2 Classical statistical models
On the statistical side of the modeling spectrum, many regression-style methods
have been used for forecasting. Perhaps the most well-known statistical method for
time series is the auto-regressive integrated moving average, or ARIMA [22]. ARIMA
models use a linear, regression-type equation in which the predictors are lags of
the dependent variable and/or lags of the forecast errors. ARIMA and seasonal
ARIMA (SARIMA) models are frequently applied to infectious disease time series
[94, 181, 184, 193, 156]. Lu et al. combined a SARIMA model with a Markov switching
model (a type of compartmental model) to account for anomalies in the surveillance
process [120].
Also under the subheading of trend and seasonal estimation are simple exponential
smoothing strategies, known as Holt-Winters models [86, 204]. Exponential smoothing
techniques involve taking weighted averages of past observations with exponentially
decreasing weights further from the present. Holt-Winters in particular is known for
its efficient and accurate predictive ability [62, 68]. These approaches have been used
successfully in forecasting dengue fever [26] and leprosy [37].
Some researchers have used generalized linear regression models to develop infec-
tious disease forecasts. In some cases, researchers used lagged covariates (e.g. temper-
ature, rainfall, or prior incidence) to predict future incidence [75, 83, 114, 132, 158].
Held and Paul also combined statistical and biological theory by building a regression
model that consisted of three components of disease incidence: endemic, epidemic, and
spatio-temporal epidemic (to account for spread of disease across locations) [80]. This
has become a well-established framework for forecasting infectious disease surveillance
data [85, 81, 156], and is accompanied by software implementing the methods [129].
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1.2.1.3 Modern statistical methods
Modern statistical methods, i.e. not the classical time-series and regression-based
approaches, are an increasingly popular way to forecast infectious disease incidence.
These methods include non-parametric approaches as well as more black-box machine-
learning style algorithms. We focus in this section on stand-alone forecasting methods,
for a discussion on ensemble methods, see Section 1.2.4.
Several papers have found that machine-learning modeling methods can outper-
form standard statistical models for infectious disease forecasting: random forests
outperformed ARIMA forecasting avian influenza [100], a maximum entropy model
outperformed logistic regression forecasting hemorrhagic fever with renal syndrome
[113], and fuzzy association rule mining outperformed logistic regression forecasting
dengue outbreaks [27]. Additionally, kernel conditional density estimation, a semi-
parametric method, was shown to have more well-calibrated probabilistic forecasts
than SARIMA and other regression-based approaches for forecasting highly variable
dengue outbreaks in San Juan, Puerto Rico [156]. Neural networks have also been
used for forecasting influenza [208] and Hepatitis A [72].
1.2.1.4 Comparisons between mechanistic and statistical models
From an epidemiological perspective, mechanistic models have several clear ad-
vantages over statistical models. They are biologically motivated, and therefore have
parameters that relate to well-established theory and can be interpreted by experts in
the field. Mechanistic models can flexibly incorporate features such as interventions
or behavioral changes, which can be critical, especially if forecasts are desired for
different intervention scenarios (see Section 1.1.3). While mechanistic models can be
built to rely heavily on previously observed data, they also can be instantiated with
very little prior data, such as in emerging outbreaks (see Section 1.2.2). Additionally,
while forecasts from statistical models are typically bounded by trends that have been
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previously observed, mechanistic models can comfortably forecast outside of previously
observed trends if the underlying states of the model call for such dynamics.
Despite these advantages, in forecasting settings where substantial historical data
is available, statistical models may prove more effective at using past observed trends
to forecast the future. Many statistical models were designed to be either more flexibly
or parsimoniously parameterized, meaning that they may be able to more easily
capture dynamics common to infectious disease time-series such as auto-regressive
correlation and seasonality. Additionally, they can be built to rely less heavily on
specific assumptions about a particular biological disease transmission model, giving
them flexibility to adapt when the data does not follow a particular pattern. In other
words, since any specified mechanistic model is necessarily a simplification of the true
underlying disease process, the question is how much will forecast accuracy suffer as a
result of the inevitable model misspecification. In many cases, heavily parameterized
mechanistic models may be more sensitive to model misspecification than a more
flexible statistical model.
Despite many unanswered questions about when and in what settings one type of
model will generally do better than the other, research that make explicit, data-driven
comparisons are fairly uncommon. Multi-team infectious disease forecasting challenges
provide some of the best data available on this important question. For forecasting
seasonal influenza, what limited data there are suggest that mechanistic and statistical
approaches show fairly similar performance, with statistical models showing a slight
advantage [125, 157, 93]. A collaborative effort during the 2014 West Africa Ebola
outbreak to forecast synthetic data showed fairly comparable results from mechanistic
and statistical models and did not make an explicit comparison between the two [198].
Summary analyses from other challenges have not been published, but we note that a
very simple quasi-mechanistic model was the best performing model in forecasting the
pattern of emergence of Chikunguya in the Americas [110, 36]. In sum, more research
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is needed to improve our understanding about whether different types of forecasting
methods can be shown to be more reliable than others in certain situations.
1.2.2 Forecasting in emergent settings
In emerging outbreak scenarios, where limited data is available, mechanistic models
may be able to take advantage of assumptions about the underlying transmission
process, enabling rudimentary forecasts even with minimal data. On the other hand,
many statistical models without assuming a mechanistic structure rely on past data to
be able to make forecasts. That said, any forecasts made in settings with limited data
must be subjected to rigorous sensitivity analyses, as such forecasts will necessarily
be heavily reliant on model assumptions.
A wide range of different mechanistic models have been used in settings where
infectious disease forecasts are desired for an emerging threat. A simple non-linear
growth model performed the best in a prospective challenge for forecasting Chikun-
gunya in the Americas [110]. Unlike many other mechanistic forecasting approaches,
this model has a small number of parameters, is easy to fit, and makes only a few
assumptions about the underlying disease process. A deterministic SEIR model was
used to forecast synthetic Ebola epidemic data, showing comparable performance to
other methods on the same data [59, 199]. A stochastic SEIR model also forecasted
synthetic Ebola data, and showed somewhat less reliable performance compared to
other methods [57]. Data-driven agent-based models have also been shown to be a
viable forecasting tool for emerging infectious diseases [197]. An SIR model, similar
to one used to forecast seasonal dengue fever and influenza, was used with a more
complex compartmental structure to forecast the spread of Ebola during the outbreak
in West Africa in 2014 [178]. A set of quasi-mechanistic models were used to forecast
Zika virus transmission during 2017 to help plan for vaccine trials [7].
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1.2.3 Using external data sources to inform forecasts
1.2.3.1 Moving beyond surveillance data
Traditional approaches to infectious disease forecasting often have relied on a single
time-series, or multiple similar time-series (e.g. incidence from multiple locations).
However, other types of epidemiological data may provide important information
about current transmission patterns.
Leveraging laboratory data, collected either through passive or active surveillance
strategies, may provide crucial data about what specific pathogens are currently being
transmitted and could inform forecasting efforts. This is an area that warrants more
research, as few efforts have tackled the challenge of having laboratory test data inform
forecasts at the population level. The most progress has been made in forecasting
influenza transmission at this level. One model uses an aggregate measure of genetic
distance of circulating influenza strains from the strains in the vaccine as a variable
to help forecast peak timing and intensity of seasonal outbreaks in the US [43, 44].
Some efforts have also been made to make strain-specific forecasts for influenza [99].
Other efforts have focused on longer-term forecasts of what strains will predominate
in a given season, with an eye towards providing information to influenza vaccine
manufacturers [134]. These efforts have moved beyond influenza, and forecasting
pathogen evolution is being worked on for a variety of different pathogens [74].
Another, and very different, kind of epidemiological data for forecasting is expert
opinion. Long seen as a useful indicator in business applications [190], expert opinion
has recently begun to be used in infectious disease applications [51, 37]. While
not traditional clinical data, expert opinion surveys leverage powerful computers,
i.e. human brains, that can synthesize historical experience with real-time data.
Intuitive interfaces can facilitate the specification of quantitative and digitally entered
forecasts from experts who need not be technically savvy, lowering the barriers to
participation and subsequent analysis [51]. In the 2016/2017 influenza season in the
15
US, a forecast model based on expert opinion was a top-performer in a CDC-led
forecasting competition (CDC FluSight Presentations, 2017). Human judgment and
expert opinion surveys are a promising area for further forecasting research, especially
in contexts with limited data availability.
1.2.3.2 Digital epidemiology
Digital epidemiology has been defined as the use of digital data for epidemiology
when the data were “not generated with the primary purpose of doing epidemiology”
[170]. Broadly speaking, this might refer to online search query data, social media
data, satellite imagery, or climate data, to name a few. These resources may hold
promise for forecasters who want to incorporate “Big Data” streams into their models.
In the past 10 years, much research has explored the potential for leveraging multiple
data streams to improve forecasting efforts, but this practice is still in its nascent
stages. So far, the utility of digital epidemiological data for forecasting has been
somewhat limited, perhaps due to challenges in our understanding of how digital
data generated by human behavior and interactions with the digital world relate to
epidemiological targets [133, 152, 170].
Perhaps the most famous and controversial example of using digital data streams to
support infectious disease prediction surround the early promising performance[65, 45]
and later dismal failure [109] of Google Flu trends to predict the influenza-like-illness in
the US. Google Flu trends was based on tracking influenza-related search terms entered
into the search engine. Although Google eventually discontinued the public face of
the project due to poor performance, criticism of the Google Flu trends approach
centered around how data was included or excluded, interpreted, and handled rather
than the algorithm that produced the actual forecasts [172, 144]. Ongoing research
on using search engine data in forecasting has continued despite the failure of Google
Flu trends, producing incremental but consistent improvements to forecast accuracy
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[212, 213, 124, 119]. To date, there has been less research investigating whether using
real-time search data could improve the timeliness of forecasts and nowcasts in settings
where reporting delays limit the utility of real-time surveillance data (see Section
1.4.1).
The use of climate data for epidemic forecasting serves as another clear example
of repurposing data for epidemiology. While climate factors are known biological
drivers of infection risk (e.g. the impact of absolute humidity on influenza virus
fitness [177], or temperature and humidity providing optimal conditions for mosquito
breeding), the evidence supporting the use of climate data in forecasting models is
mixed. Climatological factors such as temperature, rainfall, and relative humidity were
used to forecast annual counts of dengue hemorrhagic fever in provinces of Thailand
(to be seen in Chapter 2).However, only temperature and rainfall were included after
a rigorous covariate selection process and neither were included in the final model,
although subanalyses showed variation in these associations across different geographic
regions of Thailand. Climate factors were shown to improve forecasts of dengue
outbreak timing in Brazil[118], but played a less influential role in dengue forecasts
in Mexico [94]. Aggregated measures of absolute humidity have been incorporated
into influenza forecasts in the US [176, 212]. However, without clear standardization
across these studies, these mixed results may reflect heterogeneity in the spatial scales
at which forecasts are made, and in the spatial and temporal scales at which climate
factors are measured, are aggregated, and drive disease transmission.
1.2.4 Forecasting with ensembles
Ensemble forecasting models, or models that combine multiple forecasts into a
single forecast, have been the industry standard in weather forecasting for decades.
By fusing together different modeling frameworks, ensembles that have a diverse
library of models to choose from end up incorporating information from multiple
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different perspectives and sources. When appropriate methods are used to combine
the forecasts, the resulting ensemble should in theory always have better long-run
performance than any single model.
Ensembles have been increasingly used in infectious disease applications and
have shown promising results. For forecasting influenza, several model averaging
approaches have shown improved performance over individual models [210, 156].
Similar approaches have yielded similar results for dengue fever [209] and Ebola [199].
In many of these examples, however, the number and diversity of distinct modeling
approaches was fairly small. To unlock the full potential value of ensemble forecasting,
as well as understanding the added value of contributions from new and different data
sources or modeling strategies, more scalable frameworks for building forecast models
are required. There is a need to develop infrastructure and frameworks that can
facilitate the building of ensemble forecast models. This will require clear technical
definitions of modeling and forecasting standards.
1.3 Components of a Forecasting System
Due to the complex biological, social, and environmental mechanisms underlying
infectious disease transmission, the data generating process that we are attempting
to model is often unobservable. That means that we have many potential models to
choose from. How do we decide which model is the best for forecasting future targets?
We need a forecasting system that specifies how we plan to build our models, make
our forecasts, and evaluate the results in order to determine which model performs
best in our given situation. Because models perform differently depending on the
forecast target, type of forecast, model training technique, and evaluation metric, it is
important to specify the forecasting system prior to fitting the models to ensure an
optimal model selection [6].
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1.3.1 Forecast type
When building a forecasting system, the first steps are to choose the forecast target
(as described in Section 1.1.4) and type. Forecast targets are often dictated by the
goals of a public health initiative. Researchers and public health officials collaborate
to find a forecast target that is most useful for allocating resources and implementing
interventions to reduce the severity of an infectious disease outbreak. The forecast
target helps inform the selection of the forecast type, of which there are three: point,
interval, and density forecasts [40].
A point forecast is a forecast of a single value that attempts to minimize the error
between that value and the eventually observed value. The mean, median, or mode
of a predictive distribution is often used as the point forecast for a specified target.
While point forecasts are simpler to produce and interpret, they may make inaccurate
assumptions about the underlying probability distribution, leading to low-quality
forecasts. For example, a point forecast based on the mean may represent a value
for which there is actually a small likelihood of occurring (between the peaks of a
multi-modal distribution). This could mislead officials and researchers into forecasting
a medium-sized outbreak when the full distribution actually shows that the most likely
future scenarios are for either low incidence or an epidemic outbreak.
Interval forecasts supplement point forecasts with a range of likely values. The level
of a prediction interval indicates the percentage of eventually-observed outcomes that
should fall within that interval; i.e. if a model makes 100 forecasts, about 95 should
fall within the 95% prediction interval. Interval forecasts can be produced as simply
as adding symmetric bounds on either side of the point interval (often determined
parametrically) or by using more complex methods such as non-parametric bootstraps
and Bayesian posterior distributions.
Density forecasts assign probabilities to all possibly observed values to form a
distribution from which an interval or point forecast could be derived. The goal
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of a density forecast is to assign the maximum probability to the true future value.
Density estimation often requires simulation-generating methodology, which can be
more time-consuming and computationally-intensive than other techniques. Ongoing
advances in computing continue to make density forecasting methods more feasible
for researchers. Density forecasts contain the most nuanced information of all of the
forecasting methods, but are often the most difficult to interpret and communicate
to non-expert collaborators. This type of forecast may require further analysis or
interpretation to provide meaningful information to public health officials.
1.3.2 Evaluation and scoring
Armstrong [6] and Hyndman and Koehler [88] list a number of desirable features
for scoring metrics, especially for point forecasts. Each metric has both strengths
and weaknesses in different forecasting contexts. Research suggests that metrics
should be scale-independent and insensitive to degree of forecast difficulty. Oftentimes,
observations within an infectious disease time series have a Poisson distribution, in
that variability increases with the expected value of an observed value. Thus, incidence
near the seasonal peak are both larger and more variable than incidence near the
seasonal nadir and, consequently, forecasting model error will depend on the size of
the value it is forecasting. In these situations, using logged metrics can weight errors
equally across different scales [159].
Furthermore, metrics should be defined and finite in reasonable scenarios. Some
metrics may be undefined or infinite due to division by zero and sometimes this can
reveal issues with a model. However, if this happens in inappropriate contexts the
metric loses its utility. A metric should be valid in that it should agree with both
experts in the field (face validity) and most other metrics (construct validity). For
instance, even non-experts can agree that a model that forecasts negative values of
disease incidence should be considered invalid. Since forecasting model performance
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varies across metrics, we would prefer to use one that is in general agreement with
other metrics as opposed to an outlier. When forecasting, we should use an unbiased
metric that should not reward forecasts that are above (below) the target more than
those that are below (above) the target. Asymmetric cost functions can help officials
decide a course of action, however that is a separate task from forecasting disease
incidence.
For point forecasts, the current best practice is to use a metric that scales the
forecasting error against that of a reference model [88, 159, 66]. One example is the
relative mean absolute error, which divides the mean absolute error of the forecasting
model by the mean absolute error of a reference model
(
rMAE = 1/n
∑n
t=1 |yt−Ŷ forecastt |
1/n
∑n
t=1 |yt−Ŷ referencet |
)
.
An additional desirable feature that this metric has is interpretability, in that rMAE <
1 means that the forecasting model has less error than the reference model and
rMAE > 1 means that the forecasting model has more error than the reference model.
Interval forecasts can be evaluated by their coverage rate and their width; prediction
intervals should be as narrow as possible while covering a proportion of forecasts
approximately equal to that expected by its level. Gneiting and Raftery [66] describe
a useful interval evaluation metric:
Sintα (yt, ut, lt) =
1
T
T∑
t=1
(ut − lt) + 2
α
(lt − yt)I(yt < lt) + 2
α
(yt − ut)I(yt > ut)
where lt and ut are the lower and upper bounds of a (1 − α) ∗ 100% prediction
interval for observation yt and we would like to minimize the score Sintα . Forecasting
models are penalized for having wider intervals and for having observed values that fall
far outside of the intervals. Observations that fall outside of large prediction intervals
(small α) are penalized more than those that fall outside of small prediction intervals
(large α).
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Gneiting and Raftery state that a probabilistic forecast should have a distribution
that is consistent with the distribution of the observed values and that models that
assign more weight to the eventually observed values are better than those that do
not [66]. Metrics that provide incentives to meet these two criteria are “proper scoring
rules”. Gneiting and Raftery propose a number of proper scoring rules for many
different situations. A commonly used proper scoring rule is the log score (LogS
= 1/n
∑n
t=1 logP (Ŷt = yt)), which goes to 0 if all of the probability is correctly placed.
However, this method may be sensitive to outliers, as any observation with a forecasted
probability of zero causes the metric to go to negative infinity (though adjustments
can be made to avoid this). As an alternative, Funk et al. recommend using multiple
metrics to evaluate the unbiasedness, calibration, and sharpness of infectious disease
forecasts [58].
The continuous ranked probability score (CRPS) is a proper scoring rule that
measures the difference between the forecasted and observed cumulative distributions
[82]. This metric measures both the bias and the uncertainty of the forecasted density
and thus rewards forecasts that assign weight closer to the observed value, even if it
doesn’t assign much weight exactly on the observed value. A point forecast with no
uncertainty will have a CRPS equal to the absolute error of the forecast. Unbiased
forecasts with more uncertainty will have a higher CRPS than for unbiased forecasts
with less uncertainty, however biased forecasts with more uncertainty can have a
smaller CRPS than biased forecasts with less uncertainty. While CRPS is scale-
dependent, dividing the CRPS of a forecasting model by the MAE of a benchmark
model (as in the relative mean absolute error) yields a scale-independent continuous
ranked probability skill score [23, 20].
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1.3.3 Model training and testing
In order for a forecasting model to be useful for researchers or officials it needs
to be generalizable to data beyond the observations that were used for fitting. For
instance, a dengue model that perfectly forecasts monthly observations over the past
ten years, but performs worse than a reasonable guess—e.g. the average monthly
incidence—over the next five years is not very useful. We would be better off using
the reasonable guess instead of the forecasting model. Though we can never be sure
that our best model will perform well outside of our dataset, we can get a better idea
of its out-of-sample performance using model training and testing. We will illustrate
this concept with an example from Chapter 2,in which we forecasted annual dengue
hemorrhagic fever (DHF) incidence in Thailand for 76 provinces.
Prior to fitting any model, we split our data into a ‘training’ sample (for initial
model selection) and a ‘testing’ sample (for final model evaluation) [187, 78]. The
training sample is used for model experimentation and parameter tuning. The testing
sample is sequestered until we are ready to characterize the performance of our chosen
model in the final analysis. Why do we do this? Models tend to “overfit” to the data
that is used for estimating parameters, meaning that the best set of parameters for
one set of data are often not generalizable to other data. For instance, when using
least squares to fit a model, adding a new covariate – no matter how arbitrary – will
always decrease the error of the fitted model; i.e. the model residuals are always
smaller in a model with more components. We would prefer a model-selection method
that minimizes the error on the testing sample, which would be more generalizable to
new observations. In our example, we split the data so that the first 10 years (760
observations) were for training and the last 5 years (380 observations) were for testing.
Our next challenge is to train our model in such a way that we minimize the error
on the testing data – without using the testing data! There are many methods of
doing so, the most popular of which are using information criterion (AIC or BIC) or
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by sampling the training data (cross-validation or bootstrapping). These methods
each have strengths and drawbacks, the details of which are outside the scope of
this work. For further reading, the authors recommend The Elements of Statistical
Learning [78]. Bergmeir, Hyndman and Koo (2017) investigated the performance of
time-series specific cross-validation methods [12]. For our purposes, it is important
to note that these methods still tend to reward slightly more complex models that
may have more error on the testing data than a smaller model would [179]. Thus, in
addition to selecting the model that performs best by our pre-specified information
criterion or cross-validation metric, we should choose a more parsimonious model that
has more error in the training phase as a check against overfitting [141].
In our example, we ran leave-one-season-out cross validation on the training phase
data to select our model. In this procedure, we fit a model on 9 of the 10 years
to predict the final year — e.g. fitting on 2001-2010 to predict 2000. We repeated
this to predict the provinces in each of the 10 years, recorded the error for each
prediction, and then took the mean absolute error across all predictions and called it
the “cross-validation (CV) error” for a given model. We performed cross-validation for
202 models with different specifications and covariate combinations. The model that
minimized the CV error had 5 covariates, while the model that minimized the residual
error across the entire training phase had 14 covariates (Figure 1.2). In addition to the
5-covariate model, we also selected the smallest model within one standard deviation
of the smallest CV error — a univariate model — to forecast the testing phase.
We use the two models that we selected in the training phase to forecast the testing
phase. How this is executed depends on the goals of model evaluation and the features
of the model fitting process. There are several “windows” used for making testing
phase forecasts as outlined by Bergmeir and Benítez [11], of which we’ll highlight
two. When using the rolling-origin-recalibration window, we fit the model to the
training data to forecast the first testing phase observation, then we move the first
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Figure 1.2. The training error (orange, solid line), cross-validation (CV) error (blue,
dotted), and testing error (green, dashed) by number of model covariates for an applied
example. The training error is monotonically decreasing as the number of covariates
increases. The CV error is minimized at 5 covariates and better approximates the
testing error than the training error, especially for fewer covariates. The univariate
model had the least error in the testing phase.
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observation from the testing phase into the training data, re-fit the model and forecast
the second testing phase observation. We used this method in the testing phase of
our example as it is good for evaluating how a model might perform in real-time, as
more data is collected and assimilated into the model fitting process. When using
the rolling-origin-update window, we fit the model to the training data and forecast
the testing phase sequentially as in the rolling-origin-recalibration window, however
the testing data is only used as inputs for the model, which is not re-fit with the new
testing data. This method is practical for evaluating models that are computationally
intensive to fit, have specifically defined training-phase parameters that are of interest
to the research, or have enough data that additional observations will not meaningfully
affect the model fit.
However we decide to conduct our testing phase forecasts, we will compare the
results using the evaluation metric that we specified in Section 1.3.2. While not
absolutely necessary, we recommend building a simple benchmark model to which
we can compare the results of our models. This benchmark model should make a
reasonable guess at the outcome, which one would hope a trained forecasting model
can outperform. For short-term forecasts in a setting with high autocorrelation (e.g.
weekly dengue incidence), a good benchmark model could be an AR1 model that
merely predicts the last observed value. For forecasts with longer horizons or less
autocorrelation (e.g. annual dengue incidence), a good benchmark model could be
a seasonal or long-term average. In some situations, there is an “industry standard”
model that we should compare our novel methods to, such as SARIMA models for
sequential forecasts across multiple horizons. Either using a relative metric or using a
metric that can be compared to benchmark forecasts put the results from our models
in context, which is helpful to officials, reviewers at journals, and ourselves. In our
example, we evaluated the testing phase forecasts using relative mean absolute error
(rMAE) of our model over baseline forecasts based on the ten-year median incidence
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rate for each province. The univariate model had less testing phase error than the best
cross-validation model (Figure 1.2) and had about 20% less error than the baseline
forecasts (not shown).
When we are interpreting our results, we should focus on the model that per-
formed best in the testing phase, especially when that model is not the best model
from the training phase. If the best training phase model performs worse than a
more parsimonious model in the testing phase, some feel a tendency to analyze the
performance of the larger model during the training phase in their results. This is a
reasonable reaction after the many long hours that were put into collecting, cleaning,
and organizing dozens, hundreds, or even thousands of covariates that were either
not selected or were subsequently outperformed by a measly 2-covariate forecasting
model. A seemingly sound justification for such a practice is that the training phase is
usually longer than that of the testing phase. However, our goal at the outset of this
exercise was to find the model that makes the best forecasts that are generalizable
outside of our data, which is defined by the performance on the testing phase. Specific
times or places where a different model showed good results could be areas for future
forecasting activities. Prior to splitting the data into training and testing, think
about how many observations are needed for each sample; there need to be enough
training observations to properly fit the model (depending on the model type) and
there need to be enough testing observations to properly evaluate the model. With a
short time-series, there may be too few data to split and thus only cross validation
can be conducted on all of the data; in this scenario, interpretations about the model
performance will be weaker than those with a separate testing phase.
1.4 Operationalizing forecasts for public health
As we have mentioned above, making forecasts on infectious disease data is difficult
due to the culmination of a variety of factors, from the microscopic to the population
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level, which are difficult to do in any circumstances, but are compounded by logistical
issues when trying to make forecasts in real time. Logistical challenges include
assimilating newly-collected data into the forecasting framework, accounting for delays
in case reporting, and effectively communicating the model results to public health
officials.
1.4.1 Reporting delays
Making forecasts in real time introduces the dimension of reporting delays into
our forecasting models. From a disease surveillance perspective, reporting delays are
a timeliness issue which varies by features of the disease (ease of diagnosis, incubation
time), surveillance entity (local, state, or national government), transmission type
(electronic or not), and case load, as well as variability in reporting between surveillance
systems [90, 21]. From a data perspective, this means that observed values in the
recent past are subject to change.
Since most forecasting models make the assumption that values used for fitting
are fixed, we need to adapt our forecasting process by “nowcasting” observed values in
the recent past. One method of now-casting is to only include “sufficiently complete”
data up such that a forecasting model can make stable forecasts. For instance, 75%
of dengue hemorrhagic fever cases in Thailand were reported to the Thai Ministry
of Public Health within 10 weeks of infection [158]. To account for this, we ignored
the last 12 weeks (actually 6 biweeks, to be exact) before forecasting forward. In our
notation, we fit our model to data y1:(t+k−1) to make a k-step forecast, yt+k, where
k = −6. Another method of nowcasting is to use past reporting delays to model recent
incomplete counts. Höhle and an der Heiden [85] provide a framework for nowcasting
infectious disease incidence.
When case counts for prior time periods are subject to change, it is important
for researchers to have a collection of data “snapshots”, so that past situations can
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be investigated retrospectively with the information that was available at the time.
Thus, we should manage an independent database of cases as they are reported to us,
containing date of illness and incidence that is timestamped upon deposit into our
database.
1.4.2 Communication of results
Public health authorities have shown increasing interest in working with infectious
disease forecasters in the light of recent important public health crises. Starting
in 2009 with the pandemic influenza A outbreak, public health officials turned to
forecasters for estimates of burden and burden averted due to vaccines and antivirals.
During the Ebola outbreak in 2014, public health officials again turned to prediction
for specific information regarding the potential outbreak size and intervention impacts.
These efforts highlight how infectious disease forecasting can support public health
practice now and in the future.
1.4.2.1 What makes a good forecast?
Previous work in meteorology has outlined 3 distinct forecast attributes of a forecast
that contribute to its usefulness, or “goodness” [135]. If we apply these guidelines
to infectious disease forecasting, we can surmise that a forecast is good if it is (a)
consistent : reflecting the forecaster’s best judgment, (b) quality : forecasts conditions
that are actually observed during the time being forecasted, and (c) valuable: informs
policy or other decision-making that results in increased benefits to individuals or
society.
For a forecast to reflect the forecaster’s “best judgment” means that the forecast is
reasonable based on the forecaster’s expert knowledge base, prior experience, and best
and current methodology. The forecaster’s internal judgments are not usually available
for evaluation or quantification, but could say that a forecast is not a reflection of
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best judgment if we discover that a forecasting model contains an error or under some
conditions produces values outside the range of possible values.
To meet the conditions for high quality, forecasted values must correspond closely
to observed values. The field of forecast verification is so vast and specialized that
we could not possibly give it a comprehensive treatment here. Suffice it to say
that reducing error is central goal of the field of forecasting. Examples of quality
measurement approaches include the mean absolute error and the mean-squared error,
which reflect forecast accuracy. Other examples include measures of bias, skill (often
a comparison to reference models), and uncertainty [96].
Infectious disease forecasts are valuable if they are used to influence decisions.
Sometimes value can sometimes be accessed in quantitative units (e.g. lives or money
saved or lost). Forecast quality influences value to a large extent, but so do other more
qualitative features of how the forecast is communicated. For example, a forecast will
have a larger impact on decision-making if it is timely, presented clearly, and uses
meaningful units in addition to being accurate or improving on a previous system.
1.5 Conclusion and Future Directions
There has been a great deal of progress made in infectious disease forecasting,
however the field is very much still in its infancy. Forecasts of epidemics can inform
public health response and decision-making, including risk communication to the
general public, and timing and spatial targeting of interventions (e.g. vaccination
campaigns or vector control measures). However, to maximize the impact that forecasts
can have on the practice of public health, interdisciplinary teams must come together
to tackle a variety of challenges, from the technological and statistical, to the biological
and behavioral. To this end, the field of infectious disease forecasting should emphasize
the development and integration of new theoretical frameworks that can be directly
linked to tangible public health strategies.
30
To facilitate the development of scalable forecasting infrastructure and continued
research on improving forecasting, the field should focus on developing data standards
for both surveillance data and forecasts themselves. This will foster continued method-
ological development and facilitate scientific inquiry by enabling standard comparisons
across forecasting efforts. One key barrier to entry to this field is that the problems are
operationally complex: a model may be asked to forecast multiple targets at multiple
different times, using only available data at a given time. Converging on standard
language and terminology to describe these challenges is key to growing the field and
will accelerate discovery and innovation for years to come.
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CHAPTER 2
PROSPECTIVE FORECASTS OF ANNUAL DENGUE
HEMORRHAGIC FEVER INCIDENCE IN THAILAND,
2010–2014
(The contents of this chapter are published in the Proceedings of the National
Academy of Sciences of the United States of America[108], co-authored with Krzysztof
Sakrejda, Evan L. Ray, Lindsay T. Keegan, Qifang Bi, Paphanij Suangtho, Soawapak
Hinjoy, Sopon Iamsirithaworn, Suthanun Suthachana, Yongjua Laosiritaworn, Derek
A.T. Cummings, Justin Lessler, and Nicholas G. Reich, and appears here with
permission.)
Dengue hemorrhagic fever, a severe manifestation of dengue viral infection that
can cause severe bleeding, organ impairment, and even death, affects between 15,000
and 105,000 people each year in Thailand. While all Thai provinces experience at
least one DHF case most years, the distribution of cases shifts regionally from year
to year. Accurately forecasting where DHF outbreaks occur prior to the dengue
season could help public health officials prioritize public health activities. We develop
statistical models that use biologically-plausible covariates, observed by April each
year, to forecast the cumulative DHF incidence for the remainder of the year. We
perform cross-validation during the training phase (2000-2009) to select the covariates
for these models. A parsimonious model based on pre-season incidence outperforms
the 10-year median for 65% of province-level annual forecasts, reduces the mean
absolute error by 19%, and successfully forecasts outbreaks (AUC=0.84) over the
testing period (2010-2014). We find that functions of past incidence contribute most
strongly to model performance whereas the importance of environmental covariates
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varies regionally. This work illustrates that accurate forecasts of dengue risk are
possible in a policy-relevant time-frame.
2.1 Introduction
Dengue, a mosquito-borne virus prevalent throughout the tropics and sub-tropics,
infects an estimated 390 million people every year [13]. While the majority of infections
are mild or asymptomatic, the more severe forms of dengue infection – dengue shock
syndrome (DSS) and dengue hemorrhagic fever (DHF) – can result in organ failure
or death [161]. The number of symptomatic dengue infections has doubled every ten
years since 1990, in contrast to the declining incidence of most other communicable
diseases [185].
In Thailand, dengue infection is endemic with substantial annual and geographic
variation in incidence across its 76 provinces and 13 health regions (Figure 2.1). Over
the past 15 years, an average of 43,137 (range 14,952-106,320) DHF cases have been
reported to the Thailand Ministry of Public Health (MOPH) each year. Within a
typical year, incidence rates in different provinces can vary by an order of magnitude,
with some provinces experiencing less than 10 DHF cases per 100,000 population and
others over 100 per 100,000 population.
Public health officials must determine where to allocate resources to manage the
problems caused by dengue viral infection. A newly-approved vaccine may be able
to reduce the number of dengue infections, if properly regimented [53]. For those
already infected, effective case management can reduce the case-fatality rate of severe
dengue [98]. With sufficient advance notice, public health officials could implement
prevention programs and conduct interventions in regions that have the highest
epidemic risk. Effective long-term forecasts would provide more timely information to
aid in prioritizing these public health activities.
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Prior dengue forecasting efforts by members of our group and others have focused on
short time scales (weeks or months) [207, 114, 83, 158, 94]. These studies demonstrated
the importance of recent case counts and seasonality on the immediate trajectory of
dengue incidence. In 2015, the National Oceanic and Atmospheric Administration
(NOAA) and the Centers for Disease Control (CDC) hosted a competition to make
within-season forecasts for annual dengue incidence, epidemic peak, and peak height
for San Juan, Puerto Rico and Iquitos, Peru [138]. Groups that employed methods
relying solely on functions of incidence performed well relative to baseline forecasts
[209, 156] and were amongst the top performers in the competition [95].
Whether an infectious disease spreads within a population depends on the trans-
mission rate of the disease and the number of susceptible individuals [102, 105], thus
long-term forecasting models for DHF incidence may need to account for climatic
factors that could affect transmission as well as population susceptibility. Climatic
factors, such as temperature, rainfall, and humidity, may impact both the prevalence
and distribution of the dengue vector, the Aedes mosquito [97, 174, 24], as well as the
transmission efficiency of dengue virus [13, 92, 87]. During the low dengue season,
these climatic factors may be indicative of incidence in the following high dengue
season, perhaps due to their role in vector survival and larval development [30]. Even
in ideal conditions for disease transmission, there needs to be a sufficiently large
susceptible population for a disease to spread. Dengue has complex immunological
dynamics that make tracking the number of susceptible individuals within a population
difficult. The vast majority of first dengue infections are asymptomatic, while second
infections are more likely to result in severe outcomes such as DHF and DSS [28, 48].
Infection by any of its four serotypes may offer temporary immunity to the other
serotypes and lifelong immunity to the contracted serotype [161, 4, 202, 160], although
there is some evidence that repeat infections of the same serotype may occur [56, 200].
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A useful forecasting model needs to make better predictions than a baseline model
on out-of-sample observations [159]. For decades, researchers have split their data into
‘training’ and ‘testing’ samples to separate the fitting and evaluation processes [187, 78].
Cross validation is a popular technique for estimating the expected prediction error,
thus minimizing the cross-validation error on the training sample might be expected
to improve predictions over the testing sample. However, this can lead forecasters
to select models that “overfit” on the training sample and therefore do not perform
well on the testing sample [141]. Hence, it is prudent for researchers to also select a
parsimonious model with more cross-validation error that might perform better on
out-of-sample data [78, 141]. In the testing phase, using a sensible baseline model as
a comparison allows researchers to measure how much a forecasting model improves
over a benchmark in an interpretable manner [88].
Using demographic, weather, and dengue data from 2000 to 2009, we selected
two models using a cross-validated variable selection procedure to make probabilistic
forecasts of the annual DHF incidence for 2010 to 2014. We chose to predict DHF
cases because reporting for this severe form of dengue is thought to be more consistent
across time and space, while still being a primary indicator of the burden of disease
[158]. We compare the forecasts from these models to baseline forecasts derived from a
province’s median DHF incidence rate over the past ten years. We use the probabilistic
distributions to estimate the outbreak risk for each province. We investigate features
of our forecasting models, including regional variations in performance and the most
informative covariates. In doing so, we show that producing accurate forecasts that
add value for public health decision makers is a viable endeavor.
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2.2 Results
2.2.1 Models selected for forecasting
We obtained data on DHF cases (from the MOPH), population (National Statistical
Office of Thailand), and weather (NOAA) [158, 126, 127, 32, 50, 5]. These data were
summarized across time frames ranging from one month to one year to create 34
covariates for consideration by our model selection algorithm (Tables 2.1 and S1). We
calculated an additional covariate, ‘estimated relative susceptibility’, based on the
assumption that an infected person will be protected against all dengue serotypes for
a period of roughly two years [160]. We made forecasts using the data available in
April of each year, the month when the MOPH has historically finalized the incidence
reports obtained from all provinces for the prior calendar year. Hence, all “annual”
forecasts are for DHF incidence between April and December of the year they are
made. Across the 15 years used in this study, 87% of the DHF cases occurred between
April and December of each year.
We used leave-one-year-out cross validation to predict the DHF incidence across the
760 province-years in the training phase (76 provinces for each year from 2000-2009).
Of the 202 candidate models considered, the model with the smallest leave-one-year-
out-cross-validated mean absolute error (CV MAE) included five covariates: pre-season
(January-March) incidence rate, total January rainfall, mean January temperature,
mean temperature during the low dengue season (November-March, henceforth ‘low-
season’), and population size (Figure 2.2). In order to avoid overfitting on the training
phase, we also chose the model with the fewest covariates within one standard deviation
of the minimum CV MAE [78]. Using this procedure, we selected a model that included
only pre-season incidence. We refer to these models as the ‘weather, incidence, and
population (WIP) model’ and ‘incidence-only model’, respectively.
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Table 2.1. Justifications for types of covariates considered for inclusion prior to
model selection
Covariate Type Reason for inclusion
Incidence Large dengue outbreaks may temporarily deplete the sus-
ceptible population [160, 202, 4]. Larger dengue seasons
often start earlier [30].
Demographics Higher population density may facilitate dengue trans-
mission [191].
Humidity Humidity may improve the survival rate of Aedes
mosquito eggs [97, 30].
Rainfall Rainfall is essential for Aedes mosquito breeding and may
have a positive effect on dengue transmission [13, 174].
Temperature Temperatures must be warm enough for Aedes mosquitoes
to imbibe blood [24], but cool enough for optimal survival
of eggs [97].
2.2.2 Forecasting performance in the testing phase
Across the 380 province-years in the testing phase (2010-2014), forecasts from the
incidence-only model were more accurate than forecasts from the WIP model (relative
mean absolute error [rMAE]=93% [88]) and baseline forecasts derived from the 10-year
median incidence rate (rMAE=81%). The incidence-only model forecasts were closer
to the observed DHF incidence than those of the WIP model in 217 of 380 (57%)
province-years and better than baseline forecasts in 246 of 380 (65%) province-years
(Table S2). In each year, the incidence-only model outperformed both the WIP model
and the baseline forecasts in aggregate (i.e. the all-province MAE was lower and more
forecasts were closer to the observed incidences) (Figure 2.3 and Table S3). Across
all testing phase province-years, the 80% prediction interval from the incidence-only
model covered 80% of the observed DHF incidences, compared to 70% covered by the
WIP 80% prediction interval.
The testing-phase performance of each model varied across Thailand’s 13 MOPH
health regions (Figure S2). The incidence-only model performed best in 10 of 13 (77%)
regions, the WIP model performed best in 2 of 13 (15%) regions, and the baseline
forecasts performed best in 1 of 13 (8%) regions (Figure 2.4 and Table S4). The
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WIP model made better forecasts, relative to the baseline forecasts, for regions that
experience colder (MOPH regions 1, 7, and 8) or rainier (MOPH regions 11 and 12)
low seasons than for the rest of Thailand. In these regions climatic suitability for
mosquito breeding varies between years, hence a model with climate covariates can
provide a strong early indication of annual incidence. Conversely, the WIP model
performed especially poorly in Bangkok, which has consistently warm weather and
moderate rainfall from year to year.
We quantified the risk of an outbreak for each province-year using samples from
the predictive distributions of the incidence-only model. We define an ‘outbreak’ to be
when a province experiences a DHF incidence rate that is greater than two standard
deviations above its 10-year median rate. In the testing phase, there were outbreaks in
38 of 380 (10%) province-years. Across all testing phase province-years, the forecasted
outbreak probability had a strong correspondence with the likelihood of a province
experiencing an outbreak (Figure 2.5b). Correspondence was particularly good in
the 360 province-years where forecasted outbreak probabilities were less than 0.5
(Figure 2.5a). Due to the unlikely nature of outbreaks, the incidence-only model only
forecasted outbreak probabilities above 0.5 for 20 province-years (5% of all forecasts),
however 8 of the 38 (21%) outbreaks occurred during these province-years. The
incidence-only model correctly ordered the outbreak probabilities of any two randomly
chosen province-years 84% of the time (Figure 2.5c) [77].
2.3 Discussion
We have shown that it is possible to make accurate forecasts of annual dengue
hemorrhagic fever (DHF) incidence for Thailand at the province level using data
available to policy makers prior to each year’s dengue season. Testing forecasts from a
parsimonious model performed better than forecasts based on 10-year median incidence
rates. Further, this model successfully ordered provinces by their risk of experiencing
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an outbreak. These forecasts can provide timely and valuable information to policy
makers as they prepare for the coming dengue season. By integrating biological and
statistical approaches, these models push the envelope on how early it may be possible
to accurately forecast annual dengue incidence. However, further improvements are
needed for these forecasts to have their maximum impact.
The inclusion of climatic covariates did not consistently add value to forecasts
relative to the incidence-only model. While there is biological evidence that Aedes
mosquitoes are affected by climatic factors [97, 13, 24], the usage of such factors in
dengue forecasting efforts have shown mixed results [207, 114, 83, 94, 92, 174, 116, 117].
These findings suggest that the associations between climate covariates and dengue
either differ across time and space or are spurious correlations. Alternatively, climate
may be one of several necessary-but-insufficient factors, along with susceptibility and
recent incidence, whose combination results in ideal conditions for dengue transmission.
Building a forecasting model that incorporates interactions between covariates is an
area for future work.
The relative estimated susceptibility covariate was not selected for inclusion in
either of the final models. This crude approximation of a complex mechanistic feature
of disease was a component of the best six-covariate model, however that model
had a larger cross-validated mean absolute error during the training phase than the
weather, incidence, and population (WIP) model. A susceptibility term built on our
mechanistic understanding of the disease process that more accurately captures the
transient cross-protection between dengue serotypes could add value to a forecasting
model.
Although we have demonstrated our ability to successfully forecast DHF incidence
prior to the dengue season, many of the planning activities of the Thailand Ministry
of Public Health (MOPH) occur even further in advance, thus the ability to make
forecasts earlier in the year may be useful for public health policy. Historically, the
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MOPH has finalized each year’s dengue reports in the following April. This effectively
sets the earliest possible date annual forecasts can be made if they are to be based on
complete data. An accurate model of reporting delays or more timely reporting could
shift this date earlier. Likewise, forecasters could build a series of models optimized
for data available at different times of the year.
To aid in the translation of this research into practice we created sortable spread-
sheet reports with results for each year that were then disseminated within the MOPH.
These reports are used for ranking provinces based on the forecasted probability of
an outbreak and prioritizing locations for targeted interventions. This operational
interpretation of the results emphasizes the importance of the relative rankings being
accurate. The finding that 84% of the time our model would correctly rank two
randomly-selected province-years by outbreak probability directly supports the use of
these forecasts in practice.
Making timely forecasts of infectious disease incidence is a challenging but impor-
tant task. Accurate forecasts could play an important role in implementing targeted
interventions designed to reduce transmission, such as in helping to determine the
location and timing of vector control activities and the mobilization of additional
resources, as well as for reporting risk of infection to the public. Additionally, they
could play a critical role in a systematic study of how well different interventions
prevent or reduce the size of disease outbreaks. Collaborative efforts between public
health agencies and academic- or industry-based teams with predictive modeling
expertise are critical to helping propel this field forward. With the rapid growth and
maturation of disease surveillance systems worldwide, developing our understanding
of the best methods for creating and evaluating forecasts of infectious disease should
continue to be a global health priority.
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2.4 Materials and Methods
2.4.1 Weather covariate screening
To investigate the utility of weather for forecasting annual DHF incidence, we
included a variety of temperature, humidity, and rainfall covariates across several
seasonal periods (Table S1). We downloaded weather station data from the National
Oceanic and Atmospheric Administration (NOAA), which provided daily rain and
temperature estimates for weather stations in 35 provinces [126, 127]. Using the
stationaRy [89] package in R [153], we obtained integrated surface data from the
National Climatic Data Center (NCDC) [32]. These data consist of temperature
and humidity measurements from weather stations in 65 provinces (including all
35 provinces from the NOAA dataset), at six-hour intervals. For all provinces, we
downloaded monthly temperature and rainfall data on 0.5x0.5 latitude-longitude
resolution from the Earth System Research Laboratory (ESRL) at NOAA [50, 5].
For the NOAA and NCDC weather station data, we found the most consistently
reported weather station for each province and extracted the daily maximum and min-
imum temperature, maximum humidity, and rainfall. We aggregated these measures
into monthly covariates for maximum, minimum, and mean temperature, maximum
and mean humidity, and maximum and total rainfall across January, February, and
March. We also aggregated weather covariates across the “low season”, from November
through March, when fewer DHF cases have occurred historically, on average. This
time of season aligns with the dry season in Thailand, which has reduced temperatures
and precipitation as compared to the high dengue season, from April through October,
which corresponds with the rainy season.
We removed any covariates for which more than half of the aggregated observations
from one source were missing. For example with NOAA data, if 263 province-years
(half of 35 provinces for 15 years) of observations were missing for a covariate, it was
removed; as was the case for low-season minimum and maximum temperature. The
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ESRL data, from which the three covariates in the WIP model were derived, had one
observation per month and was completely reported across all provinces.
2.4.2 Relative estimated susceptibility
The estimated relative susceptibility covariate is a standardized rolling sum of cases
from the previous two years. This is based on the approximate duration of time after
infection with one dengue serotype that an individual may experience cross-protection
to a subsequent heterologous infection [160]. We calculate this quantity with the
following equations:
si,t = si,t−1 − yi,t−1
ni,t−1
+
yi,t−3
ni,t−3
si,0 =
1
10
2009∑
t=2000
yi,t
ni,t
,
where si,t is the estimated relative susceptibility, yi,t is the observed incidence, and ni,t
is the population in province i in year t. Each year, the susceptibility for the prior year
(si,t−1) is updated by removing the people who were infected in the past year (
yi,t−1
ni,t−1
),
as we assume that they are immune to one serotype of dengue and cross-protected
against the other serotypes. Furthermore, the cross-protection for people who were
infected three years prior ( yi,t−3
ni,t−3
) will have worn off and they are reintroduced to the
pool of susceptibles. We assume that each province starts with an estimated relative
susceptibility equal to the average incidence rate over the training phase (si,0). This
accounts for the fact that provinces with larger susceptible populations are more likely
to have greater incidence than provinces with smaller susceptible populations [102].
When there is no data for the year three years prior, si,0 is used in place of
yi,t−3
ni,t−3
. Using
rates instead of raw counts yields a covariate that can be compared across provinces
with different population sizes. Though there are more cases of non-hemorrhagic
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dengue fever and asymptomatic cases than observed DHF cases, DHF cases may serve
as a proxy for the underlying disease dynamics [13].
2.4.3 Model structure and estimation
The model that we used to forecast annual DHF incidence for this study is a
generalized additive model [78]. Specifically, we use a generalized additive model with
a negative binomial family, separate penalized smoothing splines for each covariate,
and province-level random effects:
Yi,t ∼ NB(ni,tλi,t, r), (2.1)
log
[
E(Yi,t)
]
= β0 + log(ni,t) + αi +
J∑
j=1
gj(xj,i,t|θ), (2.2)
αi ∼ Normal(µ, σ2). (2.3)
We model the incidence (Yi,t) for province i in year t as following a negative binomial
distribution with the mean equal to the province population (ni,t) times the incidence
rate (λi,t) and a dispersion parameter r. After a log transformation, we model the
mean of this distribution using an intercept (β0), a random effect for each province
(αi) and a cubic spline for each of J covariates (gj(xj,i,t|θ)).
To obtain predictive distribution samples, we use a two-stage procedure to incor-
porate the uncertainty from our model parameter estimates and from the negative
binomial distribution. We first draw 100 sample parameter sets from a multivariate
normal distribution with mean equal to the point estimates of the parameters (θ, µ, σ2)
from Equations (2.2)-(2.3) and covariance equal to the matrix of standard errors. Each
of these sampled parameter sets yields a corresponding λ̂i,t. We then draw 100 samples
from the negative binomial distribution given in Equation (2.1) for each λ̂i,t with the
fixed estimate of r to obtain a sample of size 10,000 from the predictive distribution
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for Yi,t. We calculate the point estimate for each province-year, Ŷi,t, as the median
of these samples from the predictive distribution. The lower and upper limits of the
80% prediction intervals were defined by taking the 10th and 90th percentiles of these
samples from the predictive distribution.
2.4.4 Model selection algorithm
To choose the covariates to include in the forecasting models, we used a forward-
backward stepwise algorithm to minimize the leave-one-year-out-cross-validated mean
absolute error (CV MAE) during the training phase [42]. Starting with a null model,
we iteratively added or removed the covariate that reduced the CV MAE the most at
each step. The model with the smallest CV MAE at the end of the iterative process
was the WIP model. To guard against the possibility of overfitting, we also selected
the nested model with the fewest covariates within one standard deviation of the WIP
model CV MAE [78], which was the incidence-only model.
In order to choose the number of knots for each covariate spline, we cross-validated
every single-covariate model varying the number of knots from 3 to 8, which we
conducted prior to the forward-backward stepwise algorithm above. We chose the
model with the fewest knots within one standard deviation of the smallest CV MAE
for each covariate. We fixed this number of knots for each covariate spline for all
multivariate models.
2.4.5 Mean absolute error
We used mean absolute error (MAE) as our metric to select models during the
training phase and relative mean absolute error (rMAE) to evaluate the models during
the testing phase. Forecasts were made on the log scale, thus our MAE took the form:
MAE =
1
Pk
∑
i,t∈k
∣∣∣log(Ŷi,t)− log(Yi,t)∣∣∣ = 1
Pk
∑
i,t∈k
∣∣∣∣∣log
(
Ŷi,t
Yi,t
)∣∣∣∣∣
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where Pk is the total number of province-years in block k, which could be the entire
training or testing phase, or subset to one year, province, or region. This form of the
MAE has the interpretation that precision is relative to magnitude; e.g. predicting
an incidence of 12 when an incidence of 7 is observed would have the same absolute
error as predicting an incidence of 120 when an incidence of 70 is observed (log(12
7
) =
log(120
70
) = 0.539).
The testing phase point predictions were compared to baseline forecasts using
rMAE, an intuitive, scalable, and stable metric for evaluating forecasts [159]:
rMAE =
MAEmodel
MAEbaseline
.
This metric can be interpreted as the percentage of error observed in the forecast-
ing model relative to that in the baseline forecasts; e.g. if MAEmodel = 0.6 and
MAEbaseline = 0.8, then the forecasting model’s predictions were 25% closer to the
observed value than the baseline forecasts.
2.4.6 Data and code availability
All data processing and analysis was performed in R version 3.3.1 (2017-03-16)
[153]. The code and data for this analysis is publicly available at https://doi.org/
10.5281/zenodo.814994.
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Figure 2.1. The temporal and spatial distribution of annual dengue hemorrhagic
fever (DHF) incidence rates in Thailand. (a) The annual DHF incidence rate, per
100,000 population, for each Thai province and year used in this study. (b) The
median annual DHF incidence rate, per 100,000 population, for each province from
2000-2014. (c) The coefficient of variation (standard deviation divided by the mean)
of the annual DHF incidence rate for each province.
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Figure 2.2. Weather, incidence, and population (WIP) model covariate fit curves.
The solid lines represent the average association between each covariate in the WIP
model and annual dengue hemorrhagic fever (DHF) incidence per 100,000 population
during the training phase, fixing all other covariates at their mean. The dashed lines
are the confidence intervals of each association, defined as two standard errors above
and below the mean association. The covariates are arranged by performance in the
Wald test from largest reduction in deviance (a) to smallest reduction in deviance (e).
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Figure 2.3. Incidence-only model forecasts for each year of the testing phase compared
to the baseline forecasts and the observed values. Forecasts for the annual dengue
hemorrhagic fever (DHF) incidence rate, per 100,000 population, from the incidence-
only model (blue triangles with gray 80% prediction intervals), baseline forecasts (red
circles), and observed values (black x’s) for each province and year in the testing
phase.
48
Best
fitted
model
Weather,
incidence,and
population
(WIP)
Incidence
only
a
0.7 0.8 1 1.2 1.4
rMAE
b
Figure 2.4. Geographic variation in model and performance. (a) The best fitted
model in the testing phase for each Ministry of Public Health (MOPH) region, which
shows spatial patterns of performance. (b) The relative mean absolute error (rMAE)
of the forecasts for each MOPH region from the models in (a) over the baseline
forecasts, i.e. the two northernmost MOPH regions show the rMAE of the WIP model
forecasts, while the rest show the rMAE of the incidence-only model forecasts. Areas
with: less error than the baseline are blue, more error than the baseline are red, and
equal to the baseline are white.
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Figure 2.5. The performance of outbreak forecasts by the incidence-only model.
(a) The proportion of province-years that observed an outbreak by their forecasted
outbreak probability, which are binned into quantiles. An outbreak is defined as an
annual dengue hemorrhagic fever (DHF) incidence rate greater than two standard
deviations above the median annual DHF incidence rate for the past ten years. For each
forecasted outbreak quantile, the black diamonds indicate the expected proportion of
province-years with an outbreak based on incidence-only model forecasts and the hollow
triangles indicate the observed proportion of province-years with an outbreak. (b)
The forecasted probability of an outbreak for each province-year in the testing phase
and whether or not an outbreak was observed. The blue loess smoothed line shows
the probability of observing an outbreak for a given forecasted outbreak probability
from the incidence-only model. (c) The receiver operating characteristic (ROC) curve
based on the incidence-only model’s sensitivity and specificity on outbreak forecasts.
The area under the ROC curve (AUC) is indicated below the line of no-discrimination
(dashed).
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CHAPTER 3
THE COVARIATE-ADJUSTED RESIDUALS ESTIMATOR
AND ITS USE IN BOTH RANDOMIZED TRIALS AND
OBSERVATIONAL SETTINGS
3.1 Introduction
Estimating the effect of an exposure on a population has a long history in observa-
tional epidemiology. In 1855, John Snow compared the mortality rates of households
in London by the company that supplied their water to locate the source of a cholera
epidemic.[183] In 1881, Louis Pasteur inoculated 50 sheep with anthrax, 25 of whom
had been vaccinated; the vaccinated sheep survived as the unvaccinated died, proving
that his anthrax vaccine was effective.[128] In 1948, Austin Bradford Hill conducted
the first modern randomized clinical trial, to evaluate a treatment for pulmonary
tuberculosis,[122, 214] and later formulated guidelines for researchers and practitioners
to transition from statistical association to causation.[84] Since then, there has been a
proliferation of methods to determine the exposure effects in randomized trials and
observational studies.[55, 33, 34, 192, 131, 168, 9]
One such method is the covariate-adjusted residuals estimator (CARE), which
was formulated to estimate the effect of an exposure on an outcome of interest
in individually randomized or cluster-randomized trials.[60, 10, 79] To implement
CARE, researchers first predict the outcome of interest using baseline covariates that
influence the outcome, while leaving out the exposure. Then they find the average
prediction error for each group; this error can be the difference between or the ratio
of the predicted and observed values (i.e. the residuals). The CARE estimate of the
exposure effect is the discrepancy between the average residuals in each group; this
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discrepancy can be a difference, ratio, or other measure. Gail et al. demonstrated
that CARE could increase the statistical power over an unadjusted estimator, while
maintaining confidence interval coverage, by using parametric regression models to
adjust for covariates that predicted the outcome in randomized trials.[60] Bennett et
al. showed that CARE made estimates that were robust to small sample sizes and
moderate imbalances in the distribution of predictive covariates.[10] To the best of
our knowledge, the use of CARE with non-parametric predicted outcomes has not
been evaluated.
CARE is commonly used in ecology under the name ‘residual index’,[91, 107, 19,
47, 171, 35] although it has received some criticism. In the ecological field of allometry,
researchers have used the residual index to estimate the effect of an exposure on the
body mass of an organism, often in observational settings rather than randomized
trials. While there are domain-specific questions about whether ordinary least squares
linear regression is being used appropriately in allometry,[70] others have questioned
the statistical validity of the residual index under any circumstances. Garcia-Berthou
stated that “even if the assumptions of the linear model hold for the original variables,
they will not hold for the residuals” and thus “the ‘residual index’ should never be
used for statistical analyses of condition or any other variable”.[61] To the best of
our knowledge, there has been no statistical theory presented to date to support the
continued use of the residual index, and thus CARE, in an observational setting.
In this manuscript, we provide new non-parametric theory that shows CARE is a
consistent estimator of the exposure effect in both randomized trials and observational
settings and which assumptions are necessary for that to hold. Our work supplements
and generalizes existing parametric results from Gail et al. for randomized trials
to observational settings. We compare CARE to existing estimators and introduce
a novel estimator for use in both randomized and observational settings that joins
CARE with methods using inverse probability of treatment weighting.[164, 167] We
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support our theory with two simulation studies and an application in an infectious
disease setting.
As an illustration, we estimate the effect of bednets on childhood mortality in a
cluster-randomized trial in Ghana as originally published by Binka et al..[10, 79, 16]
In this trial, the Kassena-Nankana region of Ghana was divided into 96 clusters,
48 of which were randomly selected to receive impregnated bednets in June 1993.
From July 1993 to June 1995, children aged 6-59 months were surveilled until they
died (the outcome of interest), they migrated out of the study area, they turned 60
months of age, or the end of the follow-up period was reached. The clusters had
138 to 439 children each, with an average of 274.4 children. The data includes age
in months at time of enrollment, sex, outcome, person-years of follow-up, and the
cluster-level exposure assignment for each child. To improve the precision of their
analysis, Binka et al. used covariate-adjusted residuals to control for the imbalanced
age distributions between the exposure levels. The authors found that bednets reduced
all-cause child mortality by 17%. Hayes and Moulton extended this analysis and found
that covariate-adjusted residuals produced a stronger effect of bednets on childhood
mortality with less variance than the unadjusted estimator, both when using the
relative rate and absolute difference.[79] We will use this case study as an example
when describing the causal framework and statistical theory, as the basis for one of
the simulation studies, and as our real data application.
3.2 Causal framework
Did bednets reduce childhood mortality in Ghana? This is a common causal
scientific question: how would a change in an exposure (e.g. bednets) change an
outcome (e.g. childhood mortality). As a result, answering causal questions require a
different approach than descriptive or predictive questions. For example, a descriptive
analysis may provide point and uncertainty estimates for the childhood mortality in
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clusters that actually received bednets and in clusters that did not receive bednets. If
we were interested in predicting childhood mortality, we would want to know whether
including a covariate for bednets added value to predictions that may use other
information (such as age and sex), regardless of whether that relationship was causal
or associative. Answering the causal question requires a deeper understanding of the
system that generates the exposure and the outcome, and encoding that understanding
in the model used for analysis.
A causal framework is an infrastructure that can guide our answering of causally-
motivated questions. The key components of a causal framework are the current
knowledge of the data-generating process (represented by a causal model); the quantity
that answers the scientific question (the causal parameter); the assumptions required
to link the causal quantity to a well-defined function of the observed data distribution
(the statistical parameter which may or may not be identifiable); and the estimation
and inference of the statistical parameter.[147, 148, 149, 151]
A causal model is a structural framework for expressing the relationships between
variables in a given setting.[147, 148, 149, 67, 46] A causal model can be expressed
graphically as a diagram, where variables are connected by edges (arrows) that originate
at a potential cause and terminate at the effect. Figure 3.1a is a diagram representing
a randomized trial, like that of our case study, where A is a binary exposure (A = 1 if
the cluster received bednets, A = 0 if the cluster did not receive bednets) and W Y
is the set of baseline covariates (the average age and percentage of children who are
female for each cluster) that influence the outcome Y (childhood mortality). There
are no edges pointing to the exposure A because the randomization procedure makes
the allocation of exposure independent of all other covariates. For this experimental
setting, we assume that this causal model describes the data generating process for
each cluster and that clusters are causally independent (i.e. the outcome for one cluster
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A Y
WY
a)
A Y
WC
WA WY
b)
Figure 3.1. Causal diagrams for randomized trials (a) and observational studies
(b). These diagrams give a visual representation of the relationships between the
variables in a causal model. Arrows are drawn from a potential cause to an effect. In
a completely randomized trial setting, the exposure A is generated independently of
all other variables and the outcome Y is influenced by both the exposure A and a set
of baseline covariates W Y . In an observational setting, the exposure A is no longer
randomized, but instead is influenced by baseline covariates. Some of these covariates
WC also influence Y , thus confounding the relationship between the exposure A and
the outcome Y . Other covariates WA only influence the exposure A and not the
outcome Y ; as before some covariates W Y only influence the outcome Y and not the
exposure A. (For simplicity, other unmeasured sources of variation are omitted; see
Appendix B.3.1 for a complete graph).
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is only influenced by that cluster’s exposure and baseline covariates and independent
of the exposures, baseline covariates, and outcomes of the other clusters).
In an observational setting (as portrayed in Figure 3.1b), the allocation to the
exposure A is not randomized and is potentially influenced by the baseline covariates.
In addition to the covariatesW Y that influence the outcome Y , but not the exposure A,
there are two new subsets of covariates. One subset of covariatesWA only influence the
exposure A, but not the outcome Y . The other subset are confounding covariates WC
that influence both the exposure A and the outcome Y and thus obscure the isolation
of the causal effect of interest. As a running example, we consider a scenario where
bednets are distributed to clusters by the determination of local health officials instead
of at random. In this scenario, consider a new baseline covariate: prior childhood
mortality rate. Places with more childhood mortality prior to the intervention may
be high risk for future childhood mortality and public health officials would want
to concentrate their efforts in these areas. Thus prior childhood mortality rate is a
confounding covariate, as it is a common cause of both the outcome and the exposure.
With the causal model specified, we can translate our scientific question into
a causal parameter. We assume that the relationships within the causal model
are autonomous, meaning that changing one relationship does not change the other
relationships, though changes to causes may result in different effects downstream.[149]
Thus, we could intervene to give impregnated bednets (A = 1) to all of the clusters
in our target population to generate the counterfactual (hypothetical) outcome Y (1),
leaving the other relationships the same. Likewise, we could intervene to put all of
the clusters in the unexposed group (A = 0) to find the counterfactual (hypothetical)
outcome Y (0), leaving the other relationships the same. With these counterfactual
outcomes, we translate this scientific question into a well-defined causal quantity,
specifically the average treatment effect (ATE):
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ATE = E[Y (1)− Y (0)]. (3.1)
This is the difference in the average childhood mortality rate if all of the clusters in
our target population received impregnated bednets (Y (1)) and if none of the clusters
received impregnated bednets (Y (0)). We cannot directly measure this parameter
because we only observe the outcomes Y corresponding to the actual exposures A
and not both counterfactual outcomes. Thus, we need to outline the conditions and
assumptions necessary to identify the causal parameter using a statistical parameter
based on the data.
In our application, we use the difference in conditional expectations between the
exposed and unexposed, adjusted for and averaged across the measured confounding
covariates, as the statistical parameter:1
Ψ = EWC
[
E(Y | A = 1,WC)− E(Y | A = 0,WC)]. (3.2)
This statistical parameter Ψ identifies the ATE under two assumptions. First, there
must be no unmeasured confounding between the exposure and the outcome, Y (a) ⊥
A | WC . Second, the ‘positivity assumption’, which states that each strata of measured
confounding covariates have a non-zero probability of assignment to each exposure
group (P(A = a|WC = wC) > 0,∀wC ∈ P(WC = wC) > 0), must hold.[150] These
assumptions are satisfied differently between randomized and observational settings.
In our example, the statistical parameter Ψ is the difference in the expected childhood
mortality among clusters with the same common causes, with and without bednets,
standardized with respect to the distribution of the confounding covariates in the
population.
1This equation is known as the “G-computation identifiability result” in causal inference.[163]
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In a randomized trial, the assumptions of no unmeasured confounding and positivity
are often satisfied naturally by the study design. If the process for allocating units
to each exposure level is truly random (i.e. a coin flip), then the exposure A is
independent of the outcome Y and the baseline covariates W Y , and thus there are no
confounding covariates. This is why the assumption of no unmeasured confounding is
also known as the ‘randomization assumption’. Without confounding covariates, all
units are equally likely to receive the exposure and the positivity assumption simplifies
to 0 < P(A = 1) < 1 (for binary exposures). Since these assumptions hold by design,
we can identify the ATE with the target statistical parameter ΨRCT , the difference in
the conditional expectation between exposure groups.
ΨRCT = E(Y |A = 1)− E(Y |A = 0). (3.3)
In a randomized trial where we observe outcome Yi for i = 1, . . . , n units with
exposure level Ai, the statistical parameter ΨRCT can be consistently estimated using
the difference in the average outcome between the exposure groups, also known as the
‘unadjusted estimator’:[140]
Ψˆunadj =
1
n1
∑
i∀Ai=1
Yi − 1
n0
∑
i∀Ai=0
Yi, (3.4)
where na is the number of units in exposure level A = a. The proof showing that the
unadjusted estimator is consistent for the statistical parameter ΨRCT in randomized
trials is in the Supplementary Materials B.3.2.
In observational settings, the study design alone does not protect against confound-
ing covariates or violations of the positivity assumption. The statistical parameter
that we used for randomized trials ΨRCT (3.3) no longer identifies the ATE, therefore
we must use the more general statistical parameter Ψ (3.2). In our running example,
prior childhood mortality both influences present childhood mortality and is used by
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public health officials to determine which clusters receive bednets. The unadjusted
estimator does not account for this common cause and thus would be biased for the
target statistical parameter Ψ (proof is in Supplementary Materials B.3.3). If we
measure all of the common causes of the exposure and the outcome WC (i.e. there
is no unmeasured confounding) then the inverse probability of treatment weighting
(IPTW) estimator can be used to estimate the statistical parameter Ψ:[164]
ΨˆIPTW =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1 | WCi )
− I(Ai = 0)
1− Pˆ(Ai = 1 | WCi )
)
Yi, (3.5)
which controls for the confounding covariates through estimates of the probability of
receiving the exposure, called ‘propensity scores’ Pˆ(A = 1 | WC).[167] If the propensity
scores are consistent for the true conditional probability of exposure given common
causes P(A = 1 | WC), the IPTW estimator is consistent for the statistical parameter
Ψ (proof in Supplementary Materials B.3.4). Notably, the propensity scores do not
need to account for other covariates that influence the exposure WA.
Positivity violations can be particularly problematic for the IPTW estimator.
In observational settings, propensity scores close to zero or one can lead to highly
variable estimates.[150] Therefore, accounting for WA is not only unnecessary, but
potentially harmful if it leads to extreme propensity scores. In randomized trials, the
IPTW estimator can account for imbalances in the distributions of covariates that
influence the outcome W Y between exposure levels, leading to efficiency gains over
the unadjusted estimator.[9, 196, 180]
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a) Unadjusted
A Y
WY
b) CARE
A Y
WY
c) IPTW
A Y
WC
WA WY
d) CARE-IPW
A Y
WC
WA WY
Figure 3.2. Diagrams that indicate which covariates are used by each estimator. (a)
The unadjusted estimator does not use any covariates and only compares the average
outcome Y between exposure levels A = 0 and A = 1. The unadjusted estimator is
consistent for the target statistical parameter in randomized settings ΨRCT (shown),
but not observational settings. (b) The covariate-adjusted residuals estimator (CARE)
incorporates baseline covariates to make predictions for the outcome Eˆ(Y | W Y = wY ).
If these baseline covariates are predictive of the outcome and imbalanced between
exposure levels, then CARE should be more efficient than the unadjusted estimator
in randomized settings. CARE is not consistent for Ψ in observational settings
with an exposure effect. (c) The inverse probability of treatment weighting (IPTW)
estimator is consistent for Ψ when its propensity scores Pˆ(A = 1 | WC = wC) are
consistently estimated in observational settings. (d) When CARE is augmented by
inverse probability weighting (CARE–IPW), it is consistent for Ψ when its propensity
scores Pˆ(A = 1 | WC = wC) are consistently estimated. CARE–IPW may be more
efficient than the IPTW estimator when accounting for WC in its predictions of the
outcome Eˆ(Y | WC = wC).
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3.3 The covariate-adjusted residuals estimator (CARE)
3.3.1 CARE in randomized trials
The covariate-adjusted residuals estimator (CARE) was proposed as a method
to estimate the coefficient for the exposure term in a parametric regression for the
outcome Y , assuming no interactions between the exposure A and baseline covariates
W Y , in randomized trials.[60, 10, 79] With CARE, the outcome Y is predicted using
only the baseline covariates W Y and not the exposure A, giving us predicted values
Eˆ(Y | W Y ). Residuals are derived for each level of exposure; these residuals are
commonly the difference between or the ratio of the predicted and observed values.
The discrepancy in the average residuals between exposure levels gives the point
estimate:
ΨˆCARE =
1
n1
∑
i∀Ai=1
[
Yi − Eˆ(Yi | W Yi )
]
︸ ︷︷ ︸
Average residual for exposed
− 1
n0
∑
i∀Ai=0
[
Yi − Eˆ(Yi | W Yi )
]
︸ ︷︷ ︸
Average residual for unexposed
(3.6)
=
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(A = 1)
− I(Ai = 0)
Pˆ(A = 0)
)(
Yi − Eˆ(Yi | WCi )
)
, (3.7)
where the number of units at each exposure level is equal to the total number of
units times the empirical probability of exposure na = n× Pˆ(A = a). To obtain the
predictions of the outcome Eˆ(Yi | WCi ), Hayes and Moulton recommend using Poisson
regression for event rates, logistic regression for binary outcomes, and linear regression
for continuous outcomes.[79]
To the best of our knowledge, we are the first to non-parametrically prove that
CARE provides a consistent estimator of the statistical parameter Ψ (3.2) and thus
the ATE in a randomized trial, where the identifiability assumptions hold by design
(Appendix B.1.1). CARE can be rearranged as the difference between the unadjusted
estimator (3.4) and a second term incorporating the predictions of the outcome:
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Predicted =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(A = 1)
− I(Ai = 0)
Pˆ(A = 0)
)
Eˆ(Yi | WCi ). (3.8)
As discussed in Section 3.2, the unadjusted estimator is consistent for the target
statistical parameter in randomized trials ΨRCT (3.3).[140] The ‘predicted’ term
converges to zero, as the estimates of the outcome do not include the exposure A and
the distributions of W Y for each group are asymptotically equivalent in a randomized
trial. In finite samples, CARE is expected to be a more efficient estimator than the
unadjusted estimator when accounting for predictive covariates that may be imbalanced
between the two groups in a randomized trial due to chance.[55, 33, 34, 192, 131, 168, 9]
When the predicted values of the outcome Eˆ(Y | W Y ) are a constant value (e.g.
zero or the mean of all observations Y¯ ) then CARE is equivalent to the unadjusted
estimator. This is plain to see in (3.8), as the average of a constant in the exposed
group is equal to the average of the same constant in the unexposed group. Thus, the
unadjusted estimator could be considered a special case of CARE.
3.3.2 CARE in observational studies
In observational studies with an exposure effect, CARE is not consistent for the
statistical parameter Ψ (3.2) and thus will not provide an estimate of the ATE,
even when the identifiability assumptions hold (Appendix B.1.2). The unadjusted
component of CARE is not consistent for Ψ because the empirical probability of
exposure Pˆ(A = 1) is not consistent for the true conditional probability of exposure
given confounding covariates P(A = 1 | WC). For the same reason, the predicted
component does not converge to zero. Therefore, CARE is not consistent for the
statistical parameter Ψ in observational studies where there are confounding covariates
WC and a non-zero effect of exposure.
Under the strong null hypothesis that there is no exposure effect for all units, CARE
is consistent for the target statistical parameter Ψ if the predicted values converge
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to the true conditional mean outcome Eˆ(Y | WC) → E(Y | WC , A) = E(Y | WC).
However, since we do not know a priori whether or not the null hypothesis is true
(which is presumably why we are trying to estimate the exposure effect), we do not
recommend for CARE to be used in observational settings.
3.3.3 Improving upon CARE with inverse probability of treatment weight-
ing
The inverse probability of treatment weighting (IPTW) estimator controls for
measured confounders by upweighting outcomes that have a rare exposure-covariate
combination (relative to a randomized trial) and downweighting those with a common
exposure-covariate combination (again relative to a randomized trial) using propensity
scores Pˆ(A = 1 | WC). As noted in Section 3.2, the IPTW estimator is consistent for
the statistical parameter Ψ (3.2) when the propensity scores are consistent for the
true conditional probability of exposure given confounding covariates P(A = 1 | WC).
This suggests that replacing the empirical probabilities of exposure Pˆ(A = 1) with
propensity scores Pˆ(A = 1 | WC) as an improvement to CARE (3.7):
ΨˆCARE−IPW =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1 | WCi )
− I(Ai = 0)
1− Pˆ(Ai = 1 | WCi )
)(
Yi − Eˆ(Yi | WCi )
)
.
(3.9)
To our knowledge, this is estimator has not been previously proposed or explored.
As shown in Appendix B.1.3, when the propensity scores are consistently estimated,
CARE–IPW is consistent for the target statistical parameter ΨRCT in randomized
trials (3.3) and Ψ in observational settings (3.2). As with CARE, we can split
CARE–IPW into two components and evaluate their expectations independently. The
first component of CARE–IPW is equivalent to the IPTW estimator (3.5), which
is consistent for the target statistical parameter Ψ when the propensity scores are
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consistently estimated. The second component incorporates the predictions of the
outcome:
Predicted =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1 | WCi )
− I(Ai = 0)
1− Pˆ(Ai = 1 | WCi )
)
Eˆ(Yi | WCi ). (3.10)
The predicted component of CARE–IPW converges to zero when the propensity scores
are consistently estimated. For each level of exposure, the numerator (with the true
conditional probability of exposure given confounding covariates) and the denominator
(with the propensity scores) converge to one, leaving the difference in predictions
Eˆ(Y | WC) for the two exposure levels across all units. Since the predictions do
not vary by exposure level (they are independent of the exposure A), the predicted
component converges to zero. Thus, CARE–IPW is consistent for the target statistical
parameter Ψ, which equals the ATE when the identifiability assumptions hold.
Each of the estimators described in this paper can be characterized as special
cases of CARE–IPW. CARE–IPW reduces to CARE when the propensity scores are
estimated with the empirical probability of exposure. CARE–IPW reduces to IPTW
when the predicted values of the outcome are all zero. CARE–IPW reduces to the
unadjusted estimator when both of the above conditions are met.
As shown in Appendix B.2, under standard regularity conditions,[194] CARE–IPW
is asymptotically normal and its asymptotic variance is equivalent to the sample
variance divided by n. We can then construct Wald-type 95% confidence intervals
using the asymptotic variance. Since CARE is a special case of CARE–IPW, its
asymptotic variance and confidence intervals can be similarly estimated.
3.4 Simulation Studies
In this section, we use simulations to compare the performance of the unadjusted,
IPTW, CARE, and CARE–IPW estimators of the statistical parameter Ψ (3.2). We
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consider two data generating processes. In Simulation 1, we consider a simple process
in which the effect of a binary exposure on a binary outcome is confounded by two
covariates. Then in Simulation 2, we consider a more realistic process, designed to
resemble the motivating data application. In all settings, there is no unmeasured
confounding and positivity holds by design; estimates can, therefore, be interpreted
causally.
We compared the performance of the estimators using bias, Monte Carlo standard
error, average standard error, confidence interval coverage, power, and type I error.
Each estimator made an estimate Ψˆs for the statistical parameter Ψ in simulation s,
s = 1, . . . , S, with a variance νs, and a confidence interval based on the estimate and
the variance. Bias is the difference between the average estimate and the statistical
parameter 1
S
∑S
s=1 Ψˆs −Ψ. Monte Carlo standard error is the standard error in the
estimates across simulations
√
V ar(Ψˆ1:S). Average standard error is the mean of the
estimated standard errors across simulations 1
S
∑S
s=1
√
νs. Confidence interval coverage
is the observed proportion of 95% confidence intervals that covered the statistical
paramater Ψ across all simulations. Power is the observed proportion of simulations
that the estimator rejected the null hypothesis of no exposure effect when there was
an exposure effect. Type I error is the observed proportion of simulations that the
estimator rejected the null hypothesis of no exposure effect when the null hypothesis
was true.
All simulations were run using R version 3.4.3.[154] Simulations were run in parallel
on 15 cores on a remote server. To maintain reproducibility and to make sure that the
same samples were drawn for each scenario (with and without an effect in randomized
and observational settings) across simulations, we set a seed for the random number
generator for each simulation based on the simulation number. The code used for this
project can be found on GitHub.
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3.4.1 Simulation 1
3.4.1.1 Setup
To observe the finite sample properties of CARE and CARE–IPW relative to those
of the unadjusted and IPTW estimators, we designed a synthetic simulation with
binary exposures and outcomes.
Consider an experiment with 96 units. For each unit in the sample, we generated
four independent baseline covariates: W1 ∼ Normal(0, 1), W2 ∼ Normal(0, 1),
W3 ∼ Uniform(0, 1), and W4 ∼ Bernoulli(p = 0.5). We simulated a randomized
trial where the exposure A was assigned with probability 0.5 as well as an observational
setting where the exposure was assigned with a probability given by logit−1[1 −
0.75∗W1− 2∗W4 + 0.5∗W2]. Each unit’s outcome was generated as
Y = I
(
UY < logit
−1[−0.25 + 0.5∗W1− 1∗W3 + 2∗W4− 1.25∗A− 0.5∗A∗W3])
with UY ∼ Uniform(0, 1). We generated the counterfactual outcomes for each unit,
Y (1), Y (0), by deterministically setting the exposure to A = 1 and A = 0, respectively.
The average treatment effect was calculated by taking the mean difference in the
counterfactual outcomes for a population of 100,000 units. We also simulated a
scenario under the null hypothesis of no exposure effect by setting the counterfactual
outcome with the exposure Y (1) equal to the counterfactual outcome without the
exposure Y (0).
We implemented the unadjusted estimator as the difference in average outcomes
between exposed and unexposed units. When estimating the propensity score, required
for the IPTW estimator and CARE–IPW, we used a logistic regression with main
terms for W1 and W4, which are the confounders in the observational setting. For the
outcome prediction, which is required for CARE and CARE–IPW, we used a logistic
regression with main terms for W1, W3, and W4, which corresponds to the correctly
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specified regression under the null. Statistical inference for all estimators was based
on the estimated influence curve, as described in Appendix B.2.
3.4.1.2 Results
Table 3.1 provides a comparison of the performance of the estimators over 5,000
repetitions of the simulation. When there was an effect, the intervention A led to
a 28.1% average reduction in the outcome. All estimators were unbiased in the
randomized trial setting, as the confidence interval coverage for each algorithm was at
or above the nominal level of 95%. By estimating the known exposure mechanism,
the IPTW estimator was more precise than the unadjusted estimator, as observed
by having smaller Monte Carlo standard errors. However, this precision gain did
not translate into improved power for the IPTW estimator due to its conservative
variance estimation. Within the estimating equation framework, an improvement in
power was achieved with both CARE and CARE–IPW, which included covariates
when predicting the outcome. Under the null, all estimators were unbiased and had
good to conservative Type I error control in a trial setting.
When there was an effect in the observational setting, the unadjusted estimator
was biased with low confidence interval coverage. By controlling for confounders
when predicting the outcome, CARE had less bias and greater confidence interval
coverage, though still less than the nominal level of 95%. However, through consistent
estimation of the propensity score and thereby control for the confounders, both the
IPTW estimator and CARE–IPW were unbiased and had nominal to conservative
confidence interval coverage. CARE–IPW achieved greater statistical power than the
IPTW estimator by having less Monte Carlo and average standard error.
When there was no effect in an observational setting, the unadjusted estimator was
again biased with low confidence interval coverage. In contrast, the IPTW estimator,
CARE, and CARE–IPW were unbiased with nominal to conservative Type I error
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Trial Exposure Estimator Bias MC SE Average SE CI coverage
Power/
Type I
error
RCT Effect
CARE–IPW 0.003 0.092 0.092 94.5% 85.4%
CARE 0.008 0.090 0.090 94.4% 85.3%
IPTW -0.001 0.094 0.148 99.7% 46.2%
Unadj -0.002 0.101 0.101 94.3% 78.1%
RCT Null
CARE–IPW 0.000 0.093 0.090 94.1% 5.9%
CARE 0.000 0.091 0.089 94.4% 5.6%
IPTW 0.000 0.095 0.167 99.9% 0.1%
Unadj -0.000 0.104 0.103 94.4% 5.6%
Obs Effect
CARE–IPW 0.000 0.115 0.115 94.5% 71%
CARE 0.062 0.082 0.081 87.4% 75.6%
IPTW -0.005 0.126 0.164 98.7% 44.6%
Unadj -0.197 0.088 0.089 41.7% 100%
Obs Null
CARE–IPW -0.004 0.107 0.102 94.1% 5.9%
CARE -0.003 0.079 0.087 96.7% 3.3%
IPTW -0.005 0.124 0.197 99.6% 0.4%
Unadj -0.219 0.100 0.099 39.7% 60.3%
Table 3.1. Results for the effect estimators in Simulation 1 by trial type and exposure.
The covariate-adjusted residuals estimator (CARE) used a logistic regression with
W1, W3, and W4 to predict the outcome. The inverse-probability of treatment
weighting (IPTW) estimator uses a logistic regression with W1 and W4 to estimate
the propensity scores. CARE with inverse probability weighting (CARE–IPW) the
same regression as CARE to predict the outcome and the same regression as IPTW
to estimate the propensity scores.
control. We note that under the null, CARE is expected to be consistent if the
outcome is correctly predicted, which it was here.
Altogether these simulations confirm the theoretical properties, described in Section
3.3.
3.4.2 Simulation 2
3.4.2.1 Setup
Here we observe the performance of CARE and CARE–IPW in a simulation inspired
by the bednet cluster-randomized trial.[79] The baseline covariates and the outcome
were generated using distributions based on the case study data. As in Simulation 1,
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we ran 5,000 repetitions of four different scenarios: two levels of exposure effect, with
an effect and under the null of no exposure effect, for exposures that were randomly
assigned and for exposures that were assigned as a function of covariates.
We generated data for 96 clusters for each simulation. The number of person-years
(M) for each cluster were drawn from a Poisson distribution with the same mean
as observed in the case study. Baseline covariates for the average age in months
(W1) and the percent of children who were female (W2) were drawn from normal
distributions with the same mean and variance as observed in the case study. An
additional covariate, prior childhood mortality rate (W3), was generated using draws
from a negative binomial distribution with a similar mean (µ) and overdispersion
parameter (r) as seen in the unexposed group of the case study. The counterfactual
for childhood mortality without bednets (Y (0)) was drawn from a negative binomial
distribution based on the number of person-years M and the baseline covariates W1,
W2, and W3 for each cluster. For trials with an exposure effect, the counterfactual
for childhood mortality with bednets (Y (1)) was a deterministic formula based on
Y (0) and the prior childhood mortality rate W3, which translates into a reduction
of about 12 deaths per thousand person-years. For trials without an exposure effect,
the two counterfactuals were equivalent Y (1) = Y (0). The data generating equations
were as follows:
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M(Person-years) ∼ Poisson(347)
W1(Average age in months) ∼ Normal(25.3, 1)
W2(Percent female) ∼ Normal(0.5, 0.03)
W3(Prior mortality rate) ∼ NegBinom(0.04∗M, r = 16)/M
µ = (0.378− 0.01∗W1− 0.25∗W2 +W3)∗M
Y (0) ∼ NegBinom(µ, r = 16)
Y (1) = Y (0), under the null
= Y (0)− (0.01 + .1∗W3)∗M , o.w.
In the randomized setting, exactly 48 clusters were assigned to both exposure levels
in each simulation. In the observational setting, the probability of exposure depended
on the prior childhood mortality rate:
P(A = 1 | W3) = Binomial(logit−1(60∗(W3− .04))).
Thus prior childhood mortality rate W3 was a common cause of both the exposure
and the outcome in the observational simulations. The observed childhood mortality
Y was the realization of the counterfactual for the observed exposure level.
In our data generating process, there were no unmeasured confounders and the
positivity assumption held by design. Therefore, the statistical parameter Ψ (3.2)
identified the ATE. To calculate the ATE, we generated a population of 100,000
clusters with the same process that generated the data for each simulation, then took
the average difference between the counterfactual outcomes.
For each simulation, we made estimates of the statistical parameter Ψ with the
unadjusted estimator, the IPTW estimator, CARE, and CARE–IPW using several
different approaches to predict the outcomes and estimate the propensity scores.
When predicting the outcome Y (with an offset for person-years M) for CARE and
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CARE–IPW, we used a main terms negative binomial generalized linear regression
with all baseline covariates (W1, W2 and W3), as well as a pair of main terms Poisson
generalized linear regressions: one using only prior childhood mortality (W3, the only
confounder in the observational setting) and the other using only age and sex (W1
and W2, as in the real trial). For estimating the propensity scores for the IPTW
estimator and CARE–IPW, we used main terms logistic generalized linear regressions
with three combinations of baseline covariates: all baseline covariates (W1, W2, and
W3), only prior childhood mortality (W3), and only age and sex (W1 and W2).
3.4.2.2 Results
Across the large generated population with an exposure effect, the ATE was -11.7
deaths per thousand person-years (from Y (1) =28.5 to Y (0) =40.3). In the simulations
of observational settings, there were an average of 47.8 (range: 27 to 64) clusters
assigned to the exposed group.
In the randomized trial simulations (Table 3.2), all of the estimators had low bias
and high confidence interval coverage. CARE, CARE–IPW, and the IPTW estimator
had less Monte Carlo standard error than the unadjusted estimator. When there was
an exposure effect, the CARE and CARE–IPW estimators had more statistical power
than the unadjusted and IPTW estimators. The average standard errors for the CARE
and CARE–IPW estimators were smaller than those of the unadjusted and IPTW
estimators. This simulation suggests that the CARE and CARE–IPW estimators offer
improvements to the unadjusted and IPTW estimators in randomized trials due to
their similar levels of bias and confidence interval coverage, greater statistical power,
and smaller variance. Results for simulations that were limited to using age W1 and
sex W2, as in the case study, are presented in the Supplementary Materials B.3.5.
In the observational simulations, CARE–IPW made unbiased forecasts with low
variability despite strong confounding between the exposure and the outcome, com-
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Exposure Estimator Bias MC SE Average SE CI coverage
Power/
Type I
error
Effect
CARE–IPW 0.00 4.66 4.55 94.1% 72.6%
CARE 0.13 4.59 4.51 94.2% 72.4%
IPTW 0.00 4.64 8.88 100% 10.9%
Unadj 0.01 5.35 5.24 94.4% 60.6%
Null
CARE–IPW -0.02 4.73 4.62 94.3% 5.7%
CARE -0.02 4.67 4.59 94.5% 5.5%
IPTW 0.00 4.72 9.98 100% 0%
Unadj 0.01 5.53 5.42 94.4% 5.6%
Table 3.2. Simulation results for the effect estimators in randomized trials with
and without an exposure. The covariate-adjusted residuals estimator (CARE) uses a
Poisson regression with the prior childhood mortality W3 as a covariate to predict
the outcome. The inverse-probability of treatment weighting (IPTW) estimator uses
a logistic regression with W3 as a covariate to estimate the propensity scores. CARE–
IPW the same regression as CARE to predict the outcome and the same regression as
IPTW to estimate the propensity scores.
paring favorably to other estimators. Both with an effect and under the null, the
unadjusted estimator had large bias and poor confidence interval coverage, indicat-
ing that there was confounding between the exposure and the outcome. When the
estimators only accounted for the confounding covariate, prior childhood mortality
W3 (Table 3.3), CARE–IPW had the least bias and the most statistical power when
there was an effect; CARE had the least Monte Carlo and average standard error,
but the most bias when there was an effect; the IPTW estimator had low bias, but
most Monte Carlo and average standard error; and all three estimators had high
confidence interval coverage. More results from the observational simulations are in
the Supplementary Materials B.3.5.2.
3.5 Case study: bednets in Ghana cluster-randomized trial
In this section, we first reproduced the findings of Hayes and Moulton, who
compared CARE to the unadjusted estimator for a cluster-randomized trial in northern
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Exposure Estimator Bias MC SE Average SE CI coverage
Power/
Type I
error
Effect
CARE–IPW -0.02 5.08 4.98 94.9% 67.3%
CARE 1.45 4.36 4.56 94.9% 61.9%
IPTW 0.26 6.10 10.08 99.9% 5.1%
Unadj 8.59 5.27 5.20 61.6% 10%
Null
CARE–IPW -0.11 5.28 5.03 94.6% 5.4%
CARE 0.13 4.40 4.62 95.8% 4.2%
IPTW 0.27 6.23 11.05 100% 0%
Unadj 9.30 5.44 5.37 58.3% 41.7%
Table 3.3. Simulation results for the effect estimators in observational studies with
and without an exposure effect. The covariate-adjusted residuals estimator (CARE)
uses a Poisson regression with the confounding covariate prior childhood mortality
W3 to predict the outcome. The inverse-probability of treatment weighting (IPTW)
estimator uses a logistic regression with the confounder W3 as a covariate to estimate
the propensity scores. CARE–IPW the same regression as CARE to predict the
outcome and the same regression as IPTW to estimate the propensity scores.
Ghana that measured the impact of impregnated bednets on child mortality.[10, 79, 16]
Then we applied the IPTW estimator and CARE–IPW on the same data and discussed
the results.
3.5.1 Setup
In the original analysis, the researchers estimated the unadjusted and covariate-
adjusted mortality rates for the exposed and unexposed groups and compared them
using the t-test. For the unadjusted estimator, the observed mortality rate (i.e. the
number of deaths per thousand followup-years) was calculated for each cluster. The
unadjusted estimate of the exposure effect was equal to the difference in the average
observed mortality rate between the exposure levels.
In the covariate-adjusted analysis, the researchers used a Poisson generalized
linear regression for mortality rate on the individual-level data using age and sex as
covariates while disregarding the cluster assignment and the exposure level. From this
regression, they predicted the expected mortality rate per follow-up year for each child,
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which they then aggregated into cluster-level predicted mortality rates per thousand
followup-years. The researchers found the residuals by taking the difference between
the predicted and observed mortality rates for each cluster. The CARE estimate of
the exposure effect was equal to the difference in the average of the residuals between
exposure levels. Hayes and Moulton used a t-test to generate confidence intervals and
conduct hypothesis testing.
We reproduced the analysis above and extended it to include IPTW and CARE–
IPW. While our estimates of the average treatment effect for CARE and the unadjusted
estimator were the same as in Hayes and Moulton, we estimated the variance using
the influence curve-based methods described in Appendix B.2 which yielded slightly
different confidence intervals and p-values. The IPTW and CARE–IPW estimators
required propensity scores. We estimated these using a main terms logistic generalized
linear regression for the exposure at the cluster level using average age in months and
percent of children who were female as covariates. These covariates may be relevant
as younger children are more vulnerable than older children and young males typically
have a higher mortality rate than young females. For CARE–IPW, we used the same
predicted values of the outcome from the individual-level regression as used for CARE.
We estimated the average treatment effect and variance for CARE and the IPTW
estimator using the methods outlined in Section 3.3.3.
3.5.2 Results
The IPTW and CARE–IPW estimates of the exposure effect were larger than the
estimates from the unadjusted estimator or CARE (Figure 3.3). As in the original
analysis, we found a mortality rate difference between the exposed group and the
unexposed group of -3.95 (95% CI: -8.46, 0.56; p-value: 0.09) per thousand followup-
years using the unadjusted estimator and -4.26 (-8.67, 0.15; p-value: 0.06) per thousand
followup-years using CARE. Using IPTW, the estimated mortality rate difference
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Estimated difference in childhood mortality rate, per thousand person−years
Figure 3.3. The estimates and 95% confidence intervals for the effect of allocating
bednets on childhood mortality rate per thousand person-years. The four estimators
used are the unadjusted estimator, the covariate-adjusted residuals estimator (CARE),
the inverse probability of treatment weighting estimator (IPTW), and CARE with
inverse probability weighting (CARE–IPW). Whie all estimates indicate that bednets
caused a reduction in childhood mortality, the CARE and CARE–IPW estimates were
more precise than those of the unadjusted and IPTW estimators.
was -5.37 (-16.94, 6.2; p-value: 0.36) per thousand followup-years. For CARE–IPW
the mortality rate difference was -5.08 (CI: -9.46, -0.7; p-value: 0.02) per thousand
followup-years. As in the simulation study, the standard error for the CARE and
CARE–IPW estimates were less than those of the unadjusted and IPTW estimates.
While IPTW had the largest estimated effect size, it also had the largest variance
of any estimator. The estimate made by CARE–IPW was larger than either the
unadjusted estimator or CARE and had the smallest variance of any estimator.
3.6 Discussion
In this paper, we provided a non-parametric statistical justification for the covariate-
adjusted residuals estimator (CARE) in randomized and observational settings, pro-
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posed a novel estimator, the covariate-adjusted residuals estimator with inverse
probability weighting (CARE–IPW), and supported the theory with a simulation
study and an application to a cluster-randomized trial. Specifically, we proved that
CARE is consistent for the average treatment effect (ATE) in randomized studies,
where there is no unmeasured confounding or violations of the positivity assumption
by design. We also proved that CARE is not consistent for the ATE in observational
settings. We developed a new estimator, CARE–IPW, which is consistent for the
ATE in observational settings when the propensity scores are consistent for the true
conditional probability of exposure given confounding covariates, and when there is
no unmeasured confounding or violations of the positivity assumption.
The unadjusted estimator, the inverse probability of treatment weighting (IPTW)
estimator, and CARE are special cases of CARE–IPW. In a randomized trial, we
would expect CARE to be more efficient than the unadjusted estimator when the
predictions for the outcome account for covariates that are predictive of the outcome
and are imbalanced between exposure levels.
The simulation studies supported our theoretical findings and suggested some
advantages to using CARE–IPW rather than CARE or the IPTW estimator. In
randomized trials, CARE and CARE–IPW had similar levels of bias and confidence
interval coverage to the comparison estimators, but with greater levels of statistical
power. In observational settings, CARE–IPW was consistent for Ψ when accounting
for the confounding covariate in the propensity score model and had greater statistical
power and less variability than the IPTW estimator. CARE had more bias than
CARE–IPW or the IPTW estimator in observational settings with an intervention
effect.
While CARE–IPW improves on CARE and IPTW, it is not a “double robust
estimator”, such as targeted maximum likelihood estimation[195] and augmented
inverse probability weighting.[173] A double robust estimator is consistent for Ψ if
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either the outcome predictions (which often include the exposure as well as baseline
covariates) or the propensity scores are consistently estimated and is the most efficient
estimator if both are. Similar to the IPTW estimator, CARE–IPW is consistent for
Ψ if and only if the propensity scores is consistently estimated. CARE–IPW may
improve efficiency over the IPTW estimator by making predictions of the outcome.
One advantage to using CARE–IPW rather than another method is that researchers
do not need to specify the relationship between the exposure and the outcome. This
can be beneficial when there is a complex relationship between the exposure and
outcome, such as multiple non-linear interactions with other covariates that augment
the strength of the exposure.
As with the IPTW estimator, CARE–IPWmay have stability issues when estimated
propensity scores approach zero or one.[150] This could be resolved in one of a
couple ways. Stabilized weights could be used to scale propensity scores away from
zero and one.[164] Alternatively, propensity scores could be replaced by incremental
propensity scores which relax the positivity assumption by looking at the effect of an
intervention when propensity scores are uniformly increased and decreased across all
observations.[104]
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CHAPTER 4
INCORPORATING FORECASTS INTO ESTIMATES OF
THE AVERAGE TREATMENT EFFECT WITH AN
APPLICATION TO ZIKA EMERGENCY OPERATIONS
CENTERS IN THAILAND
4.1 Introduction
In this paper, we investigate whether forecasts can improve estimates of the
effect of an exposure in observational settings. Observational studies can provide
useful evidence about the effect of an exposure or intervention,[18, 71, 146, 188]
but researchers need to account for covariates that can bias effect estimates.[166]
Identifying these covariates can be difficult when there are a large number of potential
causes and a small number of observations.[8, 121, 201] Using a forecasting paradigm
to perform covariate selection may improve effect estimation in specific situations.
Consider a scenario where we observe outcome Yi,t for i = 1, . . . , n units at each
time t = 1, . . . , T . For each unit-time, we observe a p-length set of baseline covariates
Xpi,t that occur prior to the outcome. For example, each time t could be a year with
the baseline covariates occurring early in the year and the outcome occurring later
in the year; both are observed at different moments within the same time period.
At exposure time T , a subset of the units receive an exposure that occurs after the
baseline covariates and prior to the outcome; Ai is a binary variable that indicates
whether unit i received the exposure at time T . A k-length subset of the baseline
covariates are the common cause covariates Xki,t, which causally influence both the
exposure (at time T ) and the outcome (across all times t). For short, we denote the
baseline covariates at the exposure time Xi = Xpi,T .
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The causal parameter that we want to estimate in this scenario is the average
treatment effect (ATE). There are two potential outcomes Yi(A = a) for each unit i at
the exposure time T , corresponding to the counterfactuals where the unit is exposed
Y (1) and unexposed Y (0). The ATE is the average difference between the potential
outcome when a unit is exposed and the potential outcome when a unit is unexposed
across all of the units in our population:
ATE = E(Y (1)− Y (0)). (4.1)
Under a set of assumptions, the ATE can be identified using the expectation of the
difference in conditional means with and without the exposure, which we denote as
the statistical parameter Ψ = EX
[
E(Y | A = 1,X)− E(Y | A = 0,X)].[167, 164, 150]
The first assumption is that the potential outcomes for each unit are dependent only
on the baseline covariates Xi and the exposure Ai for that unit at the exposure time
T , without interference from exposures or outcomes from other units. The second
assumption is that there is no unmeasured confounding, so that the potential outcomes
and the exposure are independent given our baseline covariates Y (a) ⊥ A | X. The
third assumption is that of positivity, whereby each strata of covariates have a
non-zero probability of assignment to both exposure groups (for a binary exposure)
0 < P(A = 1|X) < 1.
The positivity assumption puts a limit on the number of observations that can be
used to estimate the statistical parameter Ψ. All of the observations that occur prior
to the exposure time T have no probability of being exposed and must be excluded
from the analysis. Thus, the analysis is restricted to using the observations at the
exposure time T , which has a sample size of n. If past observations confound the
relationship between the potential outcome Y (a) and the exposure A, then those need
to be included as covariates. This would increase the number of baseline covariates Xi
and make identifying the true subset of common cause covariates Xki,T more difficult.
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We propose using a forecasting paradigm to perform covariate selection using all
of the observations prior to exposure time T . Forecasting models are not restricted
to using observations that have a non-zero probability of exposure. Instead, all of
the observations prior to time T (a total of (T − 1)∗n observations) can be used
in a covariate selection procedure to train a forecasting model for predicting the
outcome Yi,t with the baseline covariates Xpi,t. This forecasting model would then
make predictions Y˜i of the outcome at exposure time T . Subsequently, these predicted
values Y˜i would be used as a covariate for an effect estimator to estimate the statistical
parameter Ψ. With this paradigm, we can use a larger sample of observations to
estimate the relationship between the baseline covariates Xpi,t and the outcome Yi,t,
while also using a parsimonious model to make the effect estimates.
In this paper, we use two simulations to examine whether using forecasts in place
of traditional methods improves effect estimation. To do this, we make effect estimates
with two estimators and compare the estimates that use forecasting to those using
two approaches that do not use the forecasted values. We then implement the most
suitable estimators to an application in an infectious disease setting.
4.2 Case study
As a running example, we use an intervention implemented by the Thailand
Ministry of Public Health (MOPH) in response to the Zika virus global pandemic of
2016.
Dengue and Zika are flaviviruses that actively circulate in Thailand and are spread
by Aedes mosquitoes.[161, 73] Dengue, in particular, has been a major public health
priority for the MOPH, which started tracking the disease by province in 1968. A
dengue infection can cause dengue hemorrhagic fever (DHF), a severe disease that
can lead to organ failure or even death.[161] Since 2000, there has been an average of
41,795 reported DHF cases each year in Thailand, though wide-spread epidemics can
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cause over 100,000 DHF cases and require rapid, large-scale government response.[39]
By contrast, Zika virus has historically been associated with a less serious immune
response, similar to the mild manifestation of dengue, and only with the 2016 pandemic
became a public health priority.[136] There were reported Zika cases in Thailand prior
to 2016, however the virus was infrequently tested for due to its relative mildness and
similarity to dengue; from the start of surveillance by the MOPH in 2012 to 2015,
there was an average of 5 Zika cases reported per year.[169, 203, 143]
The Zika virus global pandemic changed the MOPH protocol for handling Zika
cases. During the pandemic, Zika spread to over 80 countries and territories and
was associated with a rise in neurological complications, specifically severe micro-
cephaly for newborns and Guillain–Barré syndrome in adults.[3, 106, 94, 41, 31, 101]
This led the World Health Organization to announce a public health emergency of
international concern from February to November of 2016.[73] That year, the MOPH
set up emergency operations centers (EOCs) in districts with reported cases to test
infected people, monitor high-risk populations, and recommend interventions to local
officials.[143, 2] At the end of June, there were 97 reported Zika cases in 10 provinces
and by the end of the year there were 1,114 reported Zika cases in 42 provinces (Figure
4.1).[1, 205]
While the EOCs were deployed to stem the spread of Zika, they might have affected
DHF incidence as well. Determining whether the EOCs reduced Zika incidence is
difficult because Zika incidence was inconsistently reported prior to 2016 and the
EOCs were only deployed to regions with reported Zika incidence. Furthermore, part
of the EOC’s mission was to seek out other Zika cases, so the deployments might
appear to have increased Zika incidence rather than to have decreased it. Using DHF
incidence in place of Zika cases could mitigate these issues. With the MOPH’s history
of dengue surveillance and the fact that DHF often requires hospitalization for survival,
we expect that there would be less variation in DHF reporting rates over time and
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that EOCs would not have discovered many new DHF cases that would not have
been reported anyways. Since Zika and dengue share a vector, Aedes mosquitoes, we
assume that the viruses arise under similar conditions and that interventions that
attempt to inhibit their transmission would have similar effects on their incidence.
Thus, we have a natural experiment where we can measure whether the Zika EOCs
were associated with subsequent reductions in DHF incidence.
This case study is a good example of a situation where effect estimation is difficult
and forecasts may improve inference for this effect estimate. To make accurate
estimates of effect size, we would prefer to have a large sample size, balanced numbers
of exposed and unexposed units, and a few well-known causes of both the intervention
and the outcome. In this situation, we only have 76 observations (1 outcome per
province) at our exposure time, with many more unexposed than exposed provinces (66
provinces with no EOCs vs. 10 provinces with EOCs). To further complicate matters,
there are many potential common causes of both the intervention and the outcome,
whose true relationships may be concealed by dengue’s complex transmission dynamics.
Many dengue infections are asymptomatic and multi-year cross-protection between
strains can conceal the true population susceptibility. If, for instance, provinces with
high susceptibility to dengue in a given year coincidentally had more rainfall, a model
based only on that year may disproportionately associate rainfall with DHF incidence.
By looking across multiple years, we may be able to identify the true relationships
between potential common causes and DHF incidence. In Chapter 2, we made forecasts
for DHF incidence for Thai provinces.We adapt those forecasts for use in these effect
estimation exercises.
4.2.1 Data
The exposure for this natural experiment was the deployment of an emergency
operations center (EOC) to a Thai province. The Bureau of Emerging Infectious
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Diseases released a guidebook with protocols for EOCs after a confirmed Zika case.[2]
One objective of the EOCs was to suggest prevention and control strategies to local,
provincial, and regional authorities; however we do not know the extent to which these
strategies were implemented. Since official MOPH documents both state that EOCs
should be deployed after reported Zika cases and that 10 provinces reported Zika cases
prior to 29 June 2016, we assumed that EOCs were deployed to these provinces. Thus,
we used EOC deployment as our exposure on an intention to treat basis.
The outcome of interest for this case study was the provincial DHF incidence
rate, per 100,000 population. We obtained DHF data from the MOPH and provincial
population data from the National Statistics Office of Thailand. Since the exposure
occurred prior to 29 June 2016, we aggregated the DHF incidence from July through
December of each year. We used data from 2000 to 2015 to train our forecasts for
2016. There was considerable temporal and spatial variation in DHF incidence rates
over that time period (Figure 4.2).
There were several potential sources of common causes between the Zika EOCs and
provincial DHF incidence rates. For infectious disease transmission to take place, there
needs to be an environment for transmission, infected people, and susceptible people.
To represent the environment for transmission, we used monthly temperature and
rainfall data on 0.5x0.5 latitude-longitude resolution from the Earth System Research
Laboratory at the National Oceanic and Atmospheric Administration.[50, 5] Since
the Zika EOCs were deployed between February and June, we restricted the baseline
covariates to time frames prior to February 2016. Thus, the baseline weather covariates
were monthly temperature and rainfall for the November, December, and January
immediately preceding the exposure. While the pre-intervention DHF incidence
rate (aggregated monthly from November through January) might not have been a
direct cause of a Zika EOC deployment, it could indicate that there was a suitable
environment for disease transmission by Aedes mosquitoes. Similarly, population
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after June 29
Figure 4.1. The location and timing of Zika incidence in Thailand over the course
of 2016.
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Figure 4.2. The temporal and spatial distribution of annual dengue hemorrhagic
fever (DHF) incidence rates in Thailand. (a) The annual DHF incidence rate, per
100,000 population, for each Thai province and year used in this study. (b) The
median annual DHF incidence rate, per 100,000 population, for each province from
2000-2014. (c) The coefficient of variation (standard deviation divided by the mean)
of the annual DHF incidence rate for each province.
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susceptibility to dengue is dependent on past infections, which were not direct causes of
Zika incidence. However, historical DHF incidence rates could indicate which provinces
have the environmental capacity for dengue outbreaks, and thus Zika infections. We
represented these historical DHF incidence rates with the July through December
incidence rates for each year from 2000 to 2015, as well as the minimum, median, and
maximum incidence rates for each province over that span. The number of people in
a province was a weak predictor of the DHF incidence rate, since the rate is scaled by
population. However, provincial population was strongly predictive of the deployment
of Zika EOCs because a larger population offered more opportunities for reported
Zika cases than a smaller population did. All of these relationships are depicted in
our causal diagram (Figure 4.3).
4.3 Methods
4.3.1 Forecasting paradigm
For both of the simulation studies and the case study, we selected the forecasting
model using a procedure similar to the one used in Chapter 2. In that chapter, the
data was separated into a training phase, from 2000 to 2009, and a testing phase,
from 2010 to 2014. In the training phase, a forward-backward covariate selection
process with leave-one-year-out cross validation was used to select two models to make
forecasts of DHF incidence. The first selected model had the least cross-validated mean
absolute error in the training phase. However, after cross validating over 200 different
forecasting models, the model with the least cross-validation error was likely to have
overfit to the training phase data. Thus, a parsimonious model, the model with the
least covariates with a cross-validated mean absolute error within one standard error
of the first model, was also selected. We then used these two models to prospectively
forecast the testing phase, first using all of the data from 2000-2009 to forecast 2010
then using all of the data from 2000-2010 to forecast 2011, and so on. In that chapter,
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Figure 4.3. A diagram depicting the causal model for estimating the effect
of deploying Zika emergency operations centers (EOCs) on July-December dengue
hemorrhagic fever (DHF) incidence rate. The model includes covariates that account
for provincial population, weather, and prior DHF incidence.
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the parsimonious model had less mean absolute error, higher prediction interval
coverage, and better outbreak detection in the testing phase than the model with the
least training phase error. This model selection procedure was adapted for use with
each simulation and the case study.
4.3.2 Estimators
In our simulations and case study, we estimated the statistical parameter Ψ with
several effect estimators.
The unadjusted estimator is the difference between the mean values of the exposed
and unexposed units:
Ψˆunadj =
1∑n
i=1 I(Ai = 1)
n∑
i=1
I(Ai = 1)Yi,T − 1∑n
i=1 I(Ai = 0)
n∑
i=1
I(Ai = 0)Yi,T .
(4.2)
This quantity is consistent for Ψ in randomized trials, but biased when there are
common causes that influence both the exposure A and the outcome Y . The unad-
justed estimator was used to demonstrate the bias and variability of the data in the
simulations.
The inverse probability of treatment weighting (IPTW) estimator uses ‘propensity
scores’ Pˆ(Ai = 1 | Xi), estimates of the probability of allocation to the exposure group
given baseline covariates, to estimate the statistical parameter Ψ:[167, 164]
ΨˆIPTW =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1 | Xi)
− I(Ai = 0)
1− Pˆ(Ai = 1 | Xi)
)
Yi,T . (4.3)
The IPTW estimate ΨˆIPTW is consistent for the statistical parameter Ψ if the propen-
sity scores Pˆ(Ai = 1 | Xi) consistently estimate the true conditional probability of
allocation P(Ai = 1 | Xi). The IPTW estimator is especially sensitive to the positivity
assumption. If any propensity score is equal to zero or one, then the estimate is
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undefined; extreme propensity scores can cause unstable estimates of the statistical
parameter Ψ. For this reason, we bounded the propensity scores to lie between 0.01
and 0.99.
Three methods were used to estimate the propensity scores: (1) a logistic regression
model with main terms for the baseline covariates observed at the exposure time
Pˆ(Ai = 1 | Xi); (2) a lasso penalized logistic regression model using the covariates at
the exposure time Pˆ(f`1(Ai = 1,Xi)); and (3) a logistic regression model based on
forecasted values of the outcome Pˆ(Ai = 1 | Y˜i).
As described in Chapter 3, the covariate-adjusted residuals estimator with inverse-
probability weighting (CARE–IPW) uses propensity scores as well as conditional
expectations of the outcome that are based on baseline covariates but not the exposure
Eˆ(Yi,T | Xi).The average contrast between the observed and predicted values (i.e.
residuals) for each exposure group gives an estimate for Ψ:
ΨˆCARE−IPW =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1 | Xi)
− I(Ai = 0)
1− Pˆ(Ai = 1 | Xi)
)
(Yi,T − Eˆ(Yi,T | Xi)),
(4.4)
where the propensity scores Pˆ(Ai = 1 | Xi) are the same as those used for the IPTW
estimator. As with the estimates from the IPTW estimator, the CARE–IPW estimate
ΨˆCARE−IPW is consistent for Ψ if the propensity scores consistently estimate the true
allocation probability. In some cases, the predicted values of the outcome Eˆ(Yi,T | Xi)
can lead to more efficient estimates than those made by the IPTW estimator.
Three methods were used to estimate the outcome for CARE–IPW: (1) a Poisson
generalized linear regression model with main terms for the baseline covariates observed
at the exposure time Eˆ(Yi,T | Xi); (2) a lasso penalized Poisson generalized linear
regression model using the baseline covariates at the exposure time Eˆ(f`1(Yi,T ,Xi));
and (3) a Poisson generalized linear regression model based on the forecasted values
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Estimator
Outcome
estimation
method
Propensity
score
method Xi Y˜i
Unadjusted
IPTW(G) GLM X
IPTW(L) Lasso X
IPTW(F) Forecasting X
CARE(G,G) GLM GLM X
CARE(L,L) Lasso Lasso X
CARE(F,L) Forecasting Lasso X X
CARE(L,F) Lasso Forecasting X X
CARE(F,F) Forecasting Forecasting X
Table 4.1. The estimators used in this paper by their fitting methods and covariates
used. Xi are the baseline covariates for all provinces observed at the exposure time
T . Y˜i are the forecasted values for all provinces at the exposure time T ; with the
forecasting model trained and tested on all data prior to the exposure time T .
of the outcome Eˆ(Yi,T | Y˜i). The list of estimators used in this paper and their
abbreviations are shown in Table 4.1.
Since the main terms and lasso models are restricted to be generalized linear
models, we also restricted the forecasting models to be generalized linear models.
Thus, we can measure the difference in using forecasted values attributable to having
access to more observations and from dimension reduction, rather than to using more
advanced estimation methods.
Variance estimation
We estimate the variance ν using the influence curve for each estimator. The estima-
tors used in this paper are asymptotically linear, meaning that they are asymptotically
equivalent to a sample mean of a function of the data:
Ψˆ−Ψ = 1
n
n∑
i=1
ϕ(Yi,T ) + op(1/
√
n),
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where ϕ(Y ) is the influence curve, also known as the influence function, and op(1/
√
n)
is a random variable that converges to zero in probability.[139, 165, 103] The influence
curve has mean zero and finite variance (E(ϕ(Y )) = 0, V ar(ϕ(Y )) <∞) and thus, by
the central limit theorem and Slutsky’s theorem:
√
n(Ψˆ−Ψ) d−→ Normal(0, V ar(ϕ(Y ))).
Thus, we can estimate the variance ν by taking the sample variance of each influence
curve and dividing by the total number of units n. We use this to make 95% confidence
intervals for each estimate (Ψˆ − 1.96∗√ν, Ψˆ + 1.96∗√ν). The influence curves for
CARE–IPW and IPTW can be found in the Supplementary Materials B.2.
Evaluation
In the simulations, the estimates, variances, and confidence intervals made by
each estimator were compared using bias, Monte Carlo standard error, average stan-
dard error, confidence interval coverage, and statistical power. For each simulation
s = 1, . . . , S, each estimator made an estimate Ψˆs, with variance νs, and a 95% confi-
dence interval based on the estimate and the variance. Bias is the difference between
the average estimate across simulations and the statistical parameter 1
S
∑S
s=1 Ψˆs −Ψ.
Monte Carlo standard error is the standard error in the estimates across simulations√
V ar(Ψˆ1:S). Average standard error is the mean of the estimated standard errors
across simulations 1
S
∑S
s=1
√
νs. Confidence interval coverage is the observed propor-
tion of 95% confidence intervals that covered the statistical parameter Ψ across all
simulations. Power is the observed proportion of estimates that rejected the null
hypothesis of no intervention effect in simulations where there was an intervention
effect. Type I error is the observed proportion of estimates that rejected the null
hypothesis of no intervention effect in simulations where the null hypothesis was true.
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As a secondary analysis, we were interested in whether forecasts with less error
made better estimates of Ψ. Thus, we needed metrics for evaluating the accuracy of
the forecasts for unexposed units. We only looked at the forecasts for unexposed units
because the forecasts were trained on outcomes for unexposed units. Since some units
might have been easier or more difficult to forecast, we compared our forecasts to
those of ‘median forecasts’, which was the median of the past outcomes for each unit.
We evaluated the forecasts for the outcomes in the unexposed group with forecasting
mean absolute error and relative mean absolute error. The mean absolute error (MAE)
was the average absolute difference between the forecasted value and the observed
value on the log scale MAEforecast = 1n
∑n
i=1 | log(Yi,T ) − log(Y˜i)|. We used the log
scale because all of the outcomes were estimated using Poisson generalized linear
models, which make estimates on the log scale. The relative mean absolute error
(rMAE) is the mean absolute error of the forecasting model divided by the mean
absolute error of the median forecasts:
rMAE =
MAEforecast
MAEmedian
. (4.5)
If the rMAE was less than one, the model forecast had less error than the median
forecast; if the rMAE was greater than one, the model forecast had more error than
the median forecast; if the rMAE was equal to one, the model forecast had the same
amount of error as the median forecast.
For each simulation, we compared the rMAE of the forecasts to the absolute error
and standard error of the effect estimate, as well as whether the confidence interval
covered the true statistical parameter Ψ and if the null hypothesis of no exposure effect
was correctly rejected. We fit penalized regression models to compare the forecast
accuracy by rMAE to these effect estimation metrics, accounting for the number
of exposed provinces and the average DHF incidence rate amongst the unexposed
provinces.
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4.3.2.1 Data availability
All simulations were run using R version 3.4.3.[154] Simulations were run in parallel
on 15 cores on a remote server. To maintain reproducibility and make sure that the
same samples were drawn for each scenario across simulations, we set a seed for the
random number generator for each simulation based on the simulation number. The
code used for this project can be found on GitHub.
4.4 Synthetic simulation
Prior to implementing the estimators and forecasts on real data, we conducted a
synthetic simulation where we generated the baseline covariates, exposure mechanism,
and outcomes to investigate whether forecasts could improve effect estimates in a
completely controlled setting.
4.4.1 Setup
4.4.1.1 Data generation
To relate the synthetic simulation to our case study, we generated observations
(which we called ‘incidence rates’) for 76 units (‘provinces’) at 16 times (‘years’).
We generated province-level average incidence rates αi from a Poisson distribution,
such that some provinces had naturally higher levels of incidence rates than others.
We generated 29 baseline covariates Xpi,t using a multivariate normal distribution
for all provinces and years. The first 9 baseline covariates were generated to be
similar to those of temperature, rainfall, and DHF incidence for November, December,
and January. Each covariate was highly correlated with the other covariates of the
same type (e.g. temperature), with the correlation decreasing with difference in time
(e.g. there was more correlation between November and December temperature than
between November and January temperature). The covariates were also correlated
to the other covariates of different types to a lesser degree. The correlation matrix
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demonstrating the relationships between these 9 baseline covariates is shown in
Supplementary Materials C.1. The remaining 20 covariates were random noise. The
baseline covariates for each province had an underlying p-length vector of random
effects µpi , to represent that some provinces were rainier, warmer, or had higher early
season DHF incidence than other provinces on average.
At the exposure time, we allocated interventions from a binomial distribution
with the probability determined by an inverse-logit function consisting of two of
the baseline covariates P(Ai = 1 | Xki,T ); we refer to these covariates as ‘November
temperature’ and ‘January rainfall’ to relate them to the case study, though their
names and relationships to the outcome were set arbitrarily. We drew the potential
outcome without the exposure Y (0)i,t from a Poisson distribution whose mean was
determined by a function of the province-level random effect αi and the common cause
baseline covariates Xki,T . At the exposure time T , we calculated the potential outcome
with the exposure Y (1)i,T as a function of the potential outcome without the exposure
and January rainfall, such that the expected effect size would be equal to 20. The
exposure Ai determined which potential outcome was observed at the exposure time.
We looked at two scenarios, one where the exposure Ai had an effect on Y (1)i,T and
another under the null hypothesis of no exposure effect.
αi ∼ Poisson(100)
µpi ∼ MVN(0, I)
Xpi,t ∼ MVN(µpi ,Σ)
Ai ∼ Binomial(logit−1(0.75∗Nov tempi,T + 0.75∗Jan raini,T ))
Y (0)i,t ∼ Poisson(αi + 2∗Nov tempi,t + 10∗Jan raini,t)
Y (1)i,T = Y (0)i,T , under the null
= Y (0)i,T − 20− 4∗Jan raini,T , o.w.
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We generated 50 sets of baseline covariates and outcomes prior to the exposure time.
For each set, we simulated 50 exposure allocations and outcomes at the exposure time
for a total of 2,500 simulations.
4.4.1.2 Forecasts
For the synthetic simulation, we used the first 10 years of each simulated dataset
as the training phase and the next 5 years as the testing phase. The forward-backward
covariate selection process used in the training phase chose baseline covariates to add
to a Poisson generalized linear regression model. The model that had the least error
in the testing phase was used to make forecasts for the outcome at the exposure time.
This process was run for all 50 sets of baseline covariates and outcomes that were
generated prior to the exposure time.
4.4.2 Results
4.4.2.1 Effect estimation
τ Ψτ Estimator Bias
Monte
Carlo
SE
Average
SE CI coverage Power
0 0
Unadj 13.2 4.9 4.9 22.9% –
IPTW(G) 5.4 83.1 93.7 94.0% –
IPTW(L) 9.1 5.8 21.9 100.0% –
IPTW(F) -0.8 12.2 29.5 100.0% –
20 -19.5
Unadj 15.4 5.3 5.3 17.1% 12.6%
IPTW(G) 7.3 80.3 85.7 78.6% 3.4%
IPTW(L) 12.5 5.8 20.1 99.8% 0.0%
IPTW(F) -0.1 11.6 27.4 100.0% 0.0%
Table 4.2. Results for the unadjusted and inverse probability of treatment weighting
(IPTW) estimators in the synthetic simulation. There were two effect size scenarios
(τ), the null hypothesis of no exposure effect and the alternate with an average effect
size of 20. Ψτ is the average treatment effect for each effect size, as found by taking
the average difference in the potential outcomes.
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In each simulation, there were 76 provinces with 38 of them receiving the exposure
on average (range: 24-54). The average potential outcome without the exposure was
100.2 across all units (range: 23-210), which was the same for the average potential
outcome with the exposure under the null. The average potential outcome with the
exposure when the null was false was 80.7 (range: 1-202). The average treatment
effect (Ψτ ) was -19.5 when the null was false, as in the exposure reduced the outcome
by 19.5 units.
The performance of the effect estimators varied across approaches. For reference,
the estimates from the unadjusted estimator were biased in both scenarios, with high
bias and low confidence interval coverage (Table 4.2). The IPTW(F) estimator had low
bias and high confidence interval coverage in both scenarios. The IPTW(G) estimator
had less bias than IPTW(L) or the unadjusted, but large Monte Carlo and average
standard errors. The IPTW(L) estimator had high confidence interval coverage in
both scenarios, but more bias than any estimator besides the unadjusted estimator.
All of the IPTW estimators had low statistical power.
When CARE–IPW used the forecasted values to estimate the propensity scores,
it had low bias and high confidence interval coverage in both scenarios, as well as
high statistical power when the null was false (Table 4.3). When CARE–IPW used
the forecasted values or lasso to estimate the outcomes, the Monte Carlo and average
standard errors decreased relative to the IPTW estimator using the same propensity
scores. This simulation demonstrates that using forecasted values in effect estimators
can improve effect estimates over traditional techniques, especially when the forecasted
values are used for estimating propensity scores.
4.4.2.2 Forecasts
There were two covariates associated with the outcome in the synthetic simulation,
January rainfall and November temperature, with January rainfall as the stronger
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τ Estimator Bias
Monte
Carlo
SE
Average
SE CI coverage Power
0
CARE(G,G) -0.0 12.0 11.9 97.4% –
CARE(L,L) 3.6 3.4 3.6 84.1% –
CARE(F,F) 0.3 4.2 4.1 95.2% –
CARE(L,F) -1.7 4.5 5.4 98.6% –
CARE(F,L) 0.3 2.9 3.1 95.9% –
20
CARE(G,G) 5.0 29.4 16.2 32.6% 64.8%
CARE(L,L) 8.0 3.7 4.1 48.8% 84.2%
CARE(F,F) 0.9 4.3 4.8 95.0% 98.2%
CARE(L,F) -0.5 5.0 7.2 99.1% 96.4%
CARE(F,L) 4.5 3.3 3.3 70.0% 99.6%
Table 4.3. Results for the CARE–IPW estimator in the synthetic simulation when
using different methods to estimate the outcome and the propensity scores.
of the two. Of the 50 forecasting models used to predict the exposure times in
the synthetic simulation, 50 selected January rainfall as a covariate and 43 selected
November temperature. Even though 44 forecasting models included other covariates,
the relative mean absolute error (rMAE; see Section 4.3.2) of the forecasts for the
unexposed provinces at the exposure time was below one for all simulations (mean:
0.54, range: 0.29 to 0.88), indicating that the forecasting model was always better
than the median model. This suggests that even if spurious covariates were included
in the forecasting model, they did not receive so much weight as to strongly affect the
forecasting performance.
Simulations with better forecasting accuracy had better effect estimation perfor-
mance when using the IPTW(F) and CARE(F,F) estimators. The effect estimates had
less absolute error and standard error when there was less forecast rMAE. However,
both estimator’s absolute error and the standard error were more strongly correlated
with the the mean DHF incidence rate than forecasting accuracy. The IPTW(F)
estimator was also strongly associated with the number of provinces assigned to the
exposure group. Confidence interval coverage and statistical power were not associated
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with forecast rMAE for either estimator. Figures can be found in the Supplemental
Materials C.2.
4.5 Historical simulation study
We designed a historical simulation study based on data observed prior to 2016 to
evaluate the performance of the estimators with real data.
4.5.1 Setup
4.5.1.1 Forecasts
For the historical simulation study, we alternatingly selected each year from 2000
to 2015 to be the exposure time and reorganized the other years into the training
and testing phases. For instance, when 2008 was selected to be the exposure time,
the years from 2009-2015 and 2000-2002 became the training phase while 2003-2007
became the testing phase. We used the same covariate selection process as in the
synthetic simulation, whereby the forecasting model that minimized the testing phase
mean absolute error was chosen to make forecasts at the exposure time.
4.5.1.2 Exposure allocations
For each exposure time, we simulated 100 exposure allocations at 4 effect levels τ for
a total of 6,400 simulated exposure datasets. The probability of allocation to exposure
P(Ai = 1) was based on a linear function of population, pre-exposure DHF incidence,
weather covariates, and historical DHF incidence, similar to the relationships observed
for the interventions in 2016, such that there was an average of 10 exposed provinces
each year. The exposure effect levels τ included reductions of 5, 10, and 15 cases per
100,000 population, as well as the null hypothesis of no exposure effect. For context,
from 2000 to 2015, there was an average of 37.2 (range: 0.15-336) DHF cases per
100,000 population in Thai provinces from July through December, with substantial
annual and spatial variability. We added Poisson noise to the originally observed
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values Yi,T to simulate the counterfactual outcome without exposure Yi(0) and applied
the exposure effects to determine the counterfactual outcomes with exposure Yi(1):
Ai ∼ Binomial(logit−1(−0.36∗Nov tempi,T − 0.23∗Jan raini,T + 2.4∗log(Populationi,T )
− 0.54∗Jan DHF ratei,T + 0.04∗Median DHF ratei,T ))
Yi(0) ∼ Poisson(Yi,T )
Yi(1) = Yi(0)− τ ∗Populationi,T/100, 000,
We found the statistical parameter Ψτ by taking the average difference in the
counterfactual outcomes for each exposure level τ .
4.5.2 Results
4.5.2.1 Effect estimation
The statistical parameters Ψτ and the unadjusted estimates of that parameter Ψˆτ
are presented in Table 4.4. Based on the results from the unadjusted estimator, the
historical simulation had weaker confounding than the synthetic study (as shown by
less bias and greater confidence interval coverage) and there was more variability in
the estimates (as shown with greater MC and average standard error). There was
also substantial year-to-year variability in bias and confidence interval coverage for
the unadjusted estimator (Figure 4.4).
As in the synthetic simulation, the IPTW estimator performed best when using
the forecasted values in the propensity score estimates (Table 4.4). The IPTW(G)
estimator was very biased with low confidence interval coverage. The IPTW(L) esti-
mator also had more bias and worse confidence interval coverage than the unadjusted
estimator. The IPTW(F) estimator had less bias and more confidence interval coverage
than the unadjusted estimator, though the confidence interval coverage was still below
95%. The IPTW(F) estimator had less bias than the unadjusted estimator in 64.1%
of years and as the least as much confidence interval coverage in 96.9% of years.
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τ Ψτ Estimator Bias
Monte
Carlo
SE
Average
SE CI coverage Power
0 0.0
Unadj -8.2 12.3 9.4 63.2% –
IPTW(G) -29.9 23.1 12.9 2.8% –
IPTW(L) -18.4 14.1 12.8 48.5% –
IPTW(F) -7.3 11.4 18.4 87.3% –
5 -4.7
Unadj -8.2 12.3 9.4 63.0% 52.3%
IPTW(G) -26.2 22.0 12.2 7.1% 98.6%
IPTW(L) -16.5 13.6 12.0 50.1% 64.3%
IPTW(F) -7.0 11.3 17.1 84.8% 25.9%
10 -9.1
Unadj -7.8 12.2 9.2 63.6% 63.5%
IPTW(G) -22.6 21.4 11.6 14.6% 98.9%
IPTW(L) -14.5 13.4 11.2 53.4% 74.1%
IPTW(F) -6.6 11.1 15.9 81.9% 40.9%
15 -13.0
Unadj -7.4 12.1 9.0 67.9% 73.2%
IPTW(G) -19.4 21.2 11.1 24.5% 99.2%
IPTW(L) -12.8 13.3 10.4 59.2% 81.4%
IPTW(F) -6.1 11.0 14.7 84.0% 54.6%
Table 4.4. The values of the statistical parameter Ψτ for each level of exposure τ
and the corresponding estimates by the unadjusted and IPTW estimators.
The CARE–IPW estimators varied in performance by method and effect size
(Table 4.5). The CARE(G,G) estimates were all close to zero, regardless of the year
or effect size τ . Under the null hypothesis of no effect of exposure, all of the other
CARE–IPW estimators had lower bias and higher confidence interval coverage than
the unadjusted estimator; and CARE(L,L) and CARE(L,F) had less bias and higher
confidence interval coverage than any IPTW estimator. When there was an exposure
effect, the CARE(L,F) estimator had the highest confidence interval coverage of any
estimator, with all estimates above or near the nominal 95% level. CARE(L,F) had
lower bias at higher effect levels (τ = 10, 15) than at lower effect levels. CARE(L,L)
and CARE(F,L) had low bias and high confidence interval coverage at low effect
levels, but more bias and lower confidence interval coverage at higher effect levels.
CARE(F,F) had similar levels of bias across effect levels, with better confidence
interval coverage at higher effect levels than at lower effect levels. The CARE(L,F)
100
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Figure 4.4. The performance of the unadjusted estimator across years by exposure
effect size.
estimator made estimates with less bias than the IPTW(F) estimator in 85.9% of
years and with greater confidence interval coverage in 57.8% of years.
4.5.2.2 Forecasts
Unlike the synthetic simulation, we do not know the true underlying model for
the outcome in the historical simulation. In the 16 forecasting models used in the
historical simulation (one for each season), the most commonly chosen covariates were
November temperature (13 times), November rainfall (10), and December temperature
(8).
The forecasting models performed poorly in predicting DHF incidence in the
unexposed provinces at the exposure time relative to the median model. The forecasting
rMAE was near one on average (mean: 1.02, range: 0.65 to 1.33) and had more error
than the median model 62.6% of the time. Despite the poor forecasting performance,
the effect estimators using forecasted values still had better confidence interval coverage
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τ Estimator Bias
Monte
Carlo
SE
Average
SE CI coverage Power
0
CARE(F,L) -1.8 7.2 7.0 85.4% –
CARE(L,L) -1.8 5.7 6.0 94.6% –
CARE(F,F) -4.3 10.9 10.4 82.9% –
CARE(L,F) -3.2 8.1 8.5 92.6% –
5
CARE(F,L) -0.0 7.3 7.2 88.8% 22.0%
CARE(L,L) 0.3 5.9 6.2 90.1% 17.6%
CARE(F,F) -4.0 10.9 10.9 89.4% 23.7%
CARE(L,F) -2.0 8.2 8.8 96.2% 18.9%
10
CARE(F,L) 1.7 7.3 7.5 81.1% 31.7%
CARE(L,L) 2.5 6.2 6.5 79.1% 29.2%
CARE(F,F) -3.5 10.8 11.4 93.3% 32.9%
CARE(L,F) -0.8 8.3 9.1 96.4% 32.4%
15
CARE(F,L) 3.3 7.4 7.8 75.6% 39.6%
CARE(L,L) 4.4 6.6 6.7 68.1% 36.5%
CARE(F,F) -3.0 10.7 12.0 94.7% 41.8%
CARE(L,F) 0.4 8.6 9.5 94.4% 40.2%
Table 4.5. Results for the CARE–IPW estimator in the historical simulation when
using different methods to estimate the outcome and the propensity scores.
than effect estimators that did not use forecasted values, especially for the IPTW
estimators.
When the forecasts had less rMAE, estimates from the IPTW(F) and CARE(L,F)
estimators had less absolute error. The IPTW(F) estimator also had higher confidence
interval coverage when there was less forecasting error. As in the synthetic simulations,
these metrics were more strongly correlated with the number of provinces with
the exposure and the average incidence rate in the unexposed provinces than with
forecasting rMAE. Figures can be found in the Supplemental Materials C.2.
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4.6 Application
4.6.1 Setup
We ran an analysis to determine whether Zika emergency operations centers (EOCs)
were associated with a reduction in subsequent DHF incidence in Thailand in 2016.
We considered the intervention group to be the 10 provinces that reported Zika cases
prior to 29 June 2016.
To generate our forecasts, we used the same model selection procedure as described
above, data from 2000 to 2009 as the training phase, and data from 2010 to 2015 as
the testing phase. The model that made the forecasts with the least mean absolute
error in the testing phase was used to forecast 2016.
We estimated the size of the effect associated with the deployment of the Zika
EOCs using a subset of the effect estimators. Along with the unadjusted estimator,
we used the IPTW(F) estimator, which was the best performing IPTW estimator;
the CARE(F,F) estimator, which had the most statistical power in the synthetic
simulations; and the CARE(L,F) estimator, which had the best confidence interval
coverage in the historical simulations.
4.6.2 Results
4.6.2.1 Forecasts
The covariate selection procedure chose a forecasting model for 2016 based on
November and December temperature as well as January rainfall. The forecasting
model predicted that 2016 was going to have more DHF incidence than the median
year, as the forecasted values for all 76 provinces were larger than the median DHF
incidence rates for each province. Furthermore, there were 10 forecasted outbreaks,
defined as years where the DHF incidence rate exceeds the median plus two standard
deviations for a province.
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In the end, 2016 had less DHF incidence (mean: 25.8, range: 0.5 to 206.8) than
expected; only 20 provinces exceeded their median DHF incidence rate, with only 2
experiencing outbreaks. In all, the forecasted values were larger than the observed
values in 69 of the 76 provinces; all 10 of the provinces that received the Zika EOCs had
forecasted values larger than their observed values (Figure 4.5). The mean absolute
error of the forecasted values for the provinces in the unexposed group was 1.55 and
the relative mean absolute error was 1.4. In the historic simulations, only the year
2000 had simulations with more mean absolute error and none of the simulations had
as much relative mean absolute error. While forecasts with low error are preferable,
the effect estimators were able to make accurate estimates even forecasts were poor,
in part because performance was more strongly associated with the annual DHF
incidence rate in unexposed provinces (Supplemental Materials C.2). In simulations
with annual DHF incidence rates around 25 cases per 100,000 population, the IPTW(F)
and CARE(L,F) estimators had lower than average absolute error and standard error
and above average confidence interval coverage.
Lasso regressions were used to estimate the outcomes and propensity scores for
several of the CARE–IPW estimators. The lasso regression for the CARE–IPW
outcomes had four covariates: 2010 DHF incidence rate, December rainfall, January
rainfall, and maximum DHF incidence rate since 2000.
4.6.2.2 Effect estimation
In our analysis, each of the estimators suggested that Zika interventions reduced
subsequent DHF incidence to varying degrees (Figure 4.6). The unadjusted, IPTW(F),
and CARE(F,F) estimators made similar estimates (with similarly large uncertainty)
of the difference in DHF incidence rate associated with the Zika EOCs, with each point
estimate near -15 cases per 100,000 population. Their similarity to the unadjusted
estimator suggests that the IPTW(F) and CARE(F,F) estimators did not account for
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Figure 4.5. The difference between observations and forecasts of the dengue hemor-
rhagic fever (DHF) incidence rate in each province. The circles represent forecasted
values and the x’s represent observed values. Blue lines indicate that the province is in
the control group, while orange lines indicate that the province is in the intervention
group, having reported a Zika case prior to 29 June 2016.
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Figure 4.6. The estimates and 95% confidence intervals for the intervention effect
made by selected estimators.
much confounding between the exposure and the outcome. The CARE(L,F) estimator
estimated that there was a reduction of about 8.9 cases per 100,000 population with
less uncertainty.
4.7 Discussion
In this paper, we demonstrated that forecasts can be used to improve estimates of
the effect of an intervention. In a synthetic simulation, where we could control all of the
causes of the exposure and outcome, using forecasted values in effect estimation reduced
bias and increased confidence interval coverage when using the inverse-probability of
treatment weighting (IPTW) estimator and covariate-adjusted residuals estimator
with inverse-probability weighting (CARE–IPW). In a historical simulation using
Thailand dengue hemorrhagic fever (DHF) data, which had less confounding but more
variability than the synthetic simulation, using forecasted values improved confidence
interval coverage over using lasso regression. In both simulations, when forecasts had
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less prediction error the effect estimators had less error; in the historical simulation,
forecasts with less prediction error also had greater confidence interval coverage.
Forecasting exhibited utility as a means of covariate selection and dimension
reduction, especially for propensity scores. The IPTW and CARE–IPW estimators
rely on propensity scores that account for common causes, but can be overfit to
non-confounders or random noise. By forecasting outcomes, only covariates that affect
the outcome are selected; and covariates that affect only the exposure, but not the
outcome, are not selected. By using a rigorous cross-validation and testing framework,
only the covariates with the strongest associations with the outcome are included.
Thus, propensity scores are fit only to the potentially-confounding covariates and
are unlikely to be overfit. That the IPTW and CARE–IPW effect estimates using
forecasted values performed better than those using lasso regression in the synthetic
simulation is an encouraging outcome. Lasso regression is a commonly-used method
for experiments with small sample sizes and large numbers of covariates.[78] However,
even lasso regression may be prone to picking up false signals from random noise or
collinear covariates with few observations.[121, 201] The forecasted outcomes avoided
these pitfalls due, at least in part, to the fact that the forecasting procedure was able
to use a larger sample of observations. Also of note is that the CARE–IPW estimator
performed best with a mixture of forecasted values and lasso regression. Further
investigation is required to determine which situations benefit most from the use of
forecasted values and how best to implement them.
Determining whether more accurate forecasts improve effect estimation is another
area for future work. In this paper, we restricted the forecasts to use only generalized
linear regression in order to isolate the improvement from using forecasted values for
covariate selection and dimension reduction, as opposed to the improvement from
using more advanced forecasting techniques. In the simulations, the effect estimation
error was more strongly associated with the incidence rates of the observations than
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with the accuracy of the forecasts. A focused study could provide more evidence for
the relationship between forecast accuracy on effect estimation.
We used the effect estimators with forecasted values to estimate whether emergency
operations centers (EOCs), deployed in Thailand during the 2016 Zika pandemic, were
associated with a reduction in subsequent DHF incidence. The CARE(L,F) estimate
showed a reduction of 8.9 (95% CI: 1.1, 16.7) DHF cases per 100,000 population
associated with the Zika EOCs. For this estimate to correctly identify the average
treatment effect of the Zika EOCs on DHF incidence, we assume that each province had
a non-zero probability of receiving the intervention and that there are no unmeasured
confounding covariates. We expect that every province had a non-zero probability of
reporting a Zika case and receiving a Zika EOC. One potential unmeasured confounding
covariate is the population susceptibility to dengue in each province. There is some
evidence of antibody-dependent enhancement between Zika and dengue,[38, 186] which
would mean that past dengue incidence could influence the number of Zika cases in
a province. While we included DHF incidence from past seasons, a better dengue
susceptibility metric may improve effect estimation. Additionally, due to the restriction
to generalized linear models, the forecasting and estimation models may be missing
non-linear relationships between covariates and the exposure and outcome. Using
non-parametric techniques for forecasting and for estimating outcomes and propensity
scores is an area for future work.
The methods proposed in this paper suggest that forecasts could be utilized in
other effect estimation contexts. We demonstrated that forecasts can be incorporated
into effect estimates under the following conditions: observed outcomes for a unit are
independent of the outcomes and exposures for other units; exposures are binary and
occur at a single time point; baseline covariates precede the exposure which precedes
the outcome; and that observations occur at multiple time points for the purpose of
training forecasts. While we specifically considered data where the baseline covariates,
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exposure, and outcome all occurred sequentially within a single time point, these
methods could be extended to settings where data are observed across multiple time
points. For instance, consider a situation in which researchers make weekly influenza
incidence forecasts based on previously observed influenza and weather data for a
number of school districts. Near the peak of the influenza season, the researchers
share their forecasts with school administrators and advise them to close schools for a
week to reduce influenza transmission. The school administrators (independently) use
their discretion in determining school closures, with higher risk school districts being
more likely to close. The reseachers could use the forecasts made prior to the school
closure week for the influenza incidence occurring after the school closure week in
their effect estimation process. While the relative efficiency of using forecasts against
existing methods has yet to be evaluated for this scenario, the promising results
presented in this paper warrant the exploration of incorporating forecasts into other
effect estimation settings.
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APPENDIX A
PROSPECTIVE FORECASTS OF ANNUAL DENGUE
HEMORRHAGIC FEVER INCIDENCE IN THAILAND,
2010-2014 SUPPLEMENT
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Figure A.1. Aggregated time series of dengue hemorrhagic fever cases from 2000-2014.
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Figure A.2. Map of the Thailand Ministry of Public Health administrative regions
(MOPH regions). These 13 MOPH regions are geographically clustered sets of 4-8
provinces (with the exception of Bangkok, region 0, which is its own region) co-
operatively managed by a regional health office.
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Covariate Type Covariate Name Incidence-only WIP
Incidence
estimated relative susceptibility rate
last high-season incidence rate
last post-season incidence rate
pre-season incidence rate X X
Demographics population per square kilometerprovincial population X
Humidity
maximum low-season humidity
minimum low-season humidity
mean January humidity
mean February humidity
mean March humidity
Rainfall
maximum low-season rainfall (NOAA)
total low-season rainfall (ESRL)
total low-season rainfall (NOAA)
maximum January rainfall (NOAA)
total January rainfall (ESRL) X
total January rainfall (NOAA)
maximum February rainfall (NOAA)
total February rainfall (ESRL)
total February rainfall (NOAA)
maximum March rainfall (NOAA)
total March rainfall (ESRL)
total March rainfall (NOAA)
Temperature
maximum low-season temperature (NCDC)
mean low-season temperature (ESRL) X
minimum low-season temperature (NCDC)
mean January temperature (ESRL) X
mean January temperature (NCDC)
mean January temperature (NOAA)
mean February temperature (ESRL)
mean February temperature (NCDC)
mean February temperature (NOAA)
mean March temperature (ESRL)
mean March temperature (NCDC)
mean March temperature (NOAA)
Table A.1. Covariates considered for inclusion prior to model selection. "Incidence-
only" indicates the covariates that were included in the incidence-only model. "WIP"
indicates the covariates that were included in the weather, incidence, and population
model.
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Model MAE rMAE
% of forecasts
better than
baseline
80% PI
coverage AIC
WIP 0.64 0.87 56.3 69.7 9909
Incidence-only 0.59 0.81 64.7 80.0 10055
Baseline 0.73 1.00
Table A.2. Results for each model across all regions and years in the testing phase.
Numbers in bold highlight which model performed best for each metric.
Model Year
Mean
provincial
incidence Outbreaks MAE rMAE
% of forecasts
better than
baseline
80% PI
coverage
WIP 0.53 0.73 60.5 76.3
Incidence-only 2010 78 12 0.53 0.73 68.4 80.3
Baseline 0.72 1.00
WIP 0.65 1.05 47.4 61.8
Incidence-only 2011 47 2 0.59 0.95 55.3 78.9
Baseline 0.61 1.00
WIP 0.43 0.90 60.5 86.8
Incidence-only 2012 48 1 0.43 0.90 61.8 89.5
Baseline 0.48 1.00
WIP 0.57 0.79 51.3 75.0
Incidence-only 2013 74 23 0.56 0.77 55.3 85.5
Baseline 0.73 1.00
WIP 1.00 0.89 61.8 48.7
Incidence-only 2014 24 0 0.85 0.75 82.9 65.8
Baseline 1.13 1.00
Table A.3. Annual results for each model across all regions in the testing phase.
Numbers in bold highlight which model performed best for each metric in each year.
As displayed in Table A.4, the smallest mean absolute error (MAE) by any model
for any region was for Bangkok (MOPH region 0) using the incidence-only model
(MAE=0.286). However, because the baseline MAE for Bangkok was only slightly
higher (MAE=0.289), the incidence-only model relative MAE (rMAE) was the second-
largest of any region (rMAE=0.99). Thus, even though the incidence-only model
accurately forecasted DHF incidence in Bangkok, it didn’t add much value over a
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ten-year median, due in part to there being no outbreaks in Bangkok during the
testing phase.
Conversely, the incidence-only model had about twice as much error in MOPH
region 12 (MAE=0.59) as in Bangkok. However, the baseline model had nearly three
times as much error than in Bangkok (MAE=0.86), so the incidence-only rMAE for
MOPH region 12 was the lowest of any model for any region (rMAE=0.69). Thus,
despite greater absolute error from the incidence-only model forecasts, there was more
added benefit for that region over the baseline forecasts than for Bangkok. These
examples demonstrate how MAE and rMAE can be used in tandem to give a more
complete evaluation of model performance.
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Model
MOPH
Region
#
of
Provs
Mean
provincial
incidence Outbreaks MAE rMAE
% of forecasts
better than
baseline
80% PI
coverage
WIP 0.62 0.72 68.6 65.7
Incidence 12 7 83 3 0.59 0.69 77.1 74.3
Baseline 0.86 1.00
WIP 0.58 0.84 70.0 70.0
Incidence 9 4 74 3 0.48 0.70 75.0 85.0
Baseline 0.69 1.00
WIP 0.78 0.71 70.0 66.7
Incidence 8 6 37 5 0.83 0.75 70.0 66.7
Baseline 1.10 1.00
WIP 0.56 0.82 60.0 76.0
Incidence 10 5 43 4 0.49 0.71 72.0 88.0
Baseline 0.69 1.00
WIP 0.82 0.74 77.5 50.0
Incidence 1 8 45 12 0.94 0.84 77.5 55.0
Baseline 1.11 1.00
WIP 0.56 0.76 60.0 75.0
Incidence 7 4 51 4 0.55 0.75 75.0 70.0
Baseline 0.74 1.00
WIP 0.71 0.79 62.9 62.9
Incidence 11 7 72 3 0.69 0.77 65.7 77.1
Baseline 0.90 1.00
WIP 0.51 1.01 42.5 75.0
Incidence 6 8 65 1 0.39 0.79 55.0 95.0
Baseline 0.50 1.00
WIP 0.62 0.93 48.0 72.0
Incidence 2 5 52 2 0.56 0.84 68.0 76.0
Baseline 0.66 1.00
WIP 0.60 1.04 42.5 80.0
Incidence 4 8 33 0 0.52 0.88 57.5 92.5
Baseline 0.58 1.00
WIP 0.68 1.17 52.0 64.0
Incidence 3 5 51 0 0.57 0.98 56.0 80.0
Baseline 0.58 1.00
WIP 0.58 2.00 20.0 100.0
Incidence 0 1 63 0 0.29 0.99 40.0 100.0
Baseline 0.29 1.00
WIP 0.56 1.24 37.5 77.5
Incidence 5 8 47 1 0.47 1.03 45.0 92.5
Baseline 0.46 1.00
Table A.4. Regional results for each model across all years in the testing phase.
Numbers in bold highlight which model performed best for each metric in each region.
The regions are sorted by best model performance using relative mean absolute error
(rMAE) from lowest to highest. 115
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Figure A.3. Weather, incidence, and population (WIP) model forecasts for each
year of the testing phase compared to the baseline forecasts and the observed values.
Forecasts for the annual dengue hemorrhagic fever (DHF) incidence rate, per 100,000
population, from the WIP model (blue triangles with gray 80% prediction intervals),
baseline forecasts (red circles), and observed values (black x’s) for each province and
year in the testing phase.
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Figure A.4. Geographic variation in model and performance by province. (a) The
best fitted model in the testing phase for each Thai province, which shows spatial
patterns of performance. (b) The relative mean absolute error of the forecasts for
each province from the models in (a) over the baseline forecasts. Provinces with: less
error than the baseline are blue, more error than the baseline are red, and equal to
the baseline are white.
The receiver operating characteristic (ROC) curves for the incidence-only and WIP
model outbreak forecasts for the testing phase are both significantly above the line
of no-discrimination, but are not significantly different from each other (Figure A.5).
The incidence-only model area under the ROC curve (AUC; Estimate: 84.2%, 95%CI:
78.5-89.9%) was slightly larger than that of the WIP model AUC (82.9%, 76.3-89.6%).
The sensitivity of the WIP model is marginally larger than that of the incidence-only
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model when specificity is large, suggesting that the WIP model showed very slightly
better performance than the incidence-only model at larger outbreak thresholds.
The predictive distributions samples used to make the outbreak forecasts could
have been obtained by estimating parameters in a Bayesian framework, including
drawing posterior samples of the dispersion parameter, which may have changed the
predictive performance of the models. However, due to the coverage rates observed by
our model (80% of forecasts covered by the 80% prediction interval), we did not believe
it would be worth the additional computational complexity to use these methods.
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Figure A.5. Comparison of receiver operating characteristic (ROC) curves by model.
The ROC curve based on the incidence-only model and weather, incidence, and
population (WIP) models’ sensitivity and specificity on outbreak forecasts during
the testing phase. Both curves are comfortably above the line of no-discrimination
(dashed), indicating that their outbreak forecasts are better than random. The AUC
for the WIP model (82.9%) is a bit lower than that of the incidence-only model
(84.2%).
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APPENDIX B
THE COVARIATE-ADJUSTED RESIDUALS ESTIMATOR
AND ITS USE IN BOTH RANDOMIZED TRIALS AND
OBSERVATIONAL SETTINGS APPENDIX AND
SUPPLEMENTAL MATERIALS
B.1 Proofs
B.1.1 CARE in randomized trials
Theorem 1: In a randomized trial, the expectation of the covariate adjusted residuals
estimator is equivalent to the expectation of the unadjusted estimator and is thus
consistent for the target statistical parameter Ψ.
Proof : We can split the CARE equation (3.7) into an unadjusted component and a
predicted component as such:
ΨˆCARE =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(A = 1)
− I(Ai = 0)
Pˆ(A = 0)
)
Yi
− 1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(A = 1)
− I(Ai = 0)
Pˆ(A = 0)
)
Eˆ(Yi | W Yi ) (B.1)
The unadjusted component is equivalent to the unadjusted estimator (3.4), which is
consistent for the statistical parameter ΨRCT (see Supplementary Materials B.3.2).
Using Yˆ ≡ Eˆ(Y | W Y ), we can find the expectation of the predicted component:
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E[
I(A = 1)
Pˆ(A = 1)
Yˆ
]
− E
[
I(A = 0)
Pˆ(A = 0)
Yˆ
]
=
∑
wY ,a,yˆ
I(A = 1)
Pˆ(A = 1)
yˆP(Yˆ = yˆ | A = a,W Y = wY )P(A = a | W Y = wY )P(W Y = wY )
−
∑
wY ,a,yˆ
I(A = 0)
Pˆ(A = 0)
yˆP(Yˆ = yˆ | A = a,W Y = wY )P(A = a | W Y = wY )P(W Y = wY )
=
∑
wY ,yˆ
yˆP(Yˆ = yˆ | W Y = wY )P(W Y = wY )−
∑
wY ,yˆ
yˆP(Yˆ = yˆ | W Y = wY )P(W Y = wY )
= 0,
where summations generalize to integrals for continuous random variables. In the
second equality, we used that in a randomized trial P(A = a | W Y = wY ) = P(A = a)
and that the predictions Yˆ are independent of the exposure A.
Therefore, the expectation of CARE is equivalent to the expectation of the unad-
justed estimator and is thus is consistent for the statistical parameter ΨRCT , which
identifies the average treatment effect in randomized trials, where identifiability as-
sumptions hold by design.
Corollary 1.1: If Yˆ is a constant (e.g. 0 or the mean of all Y ), CARE is equivalent
to the unadjusted estimator.
Proof : As stated previously, the unadjusted component of CARE (B.1) is equivalent to
the unadjusted estimator. If Yˆ is equal to a constant C, then the predicted component
of CARE is equivalent to:
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(A = 1)
− I(Ai = 0)
Pˆ(A = 0)
)
C =
1
n1
∑
i∈Ai=1
C − 1
n0
∑
i∈Ai=0
C
=
n1
n1
C − n0
n0
C
= 0.
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Thus CARE is equivalent to the unadjusted estimator when the predicted component
is equal to any constant.
B.1.2 CARE in observational studies
Theorem 2: In observational settings, where the allocation process is a function of
covariates, the covariate-adjusted residuals estimator will be biased for the statistical
parameter Ψ.
Proof : The unadjusted component of CARE is equivalent to the unadjusted estimator,
which is biased for the statistical parameter Ψ because the outcome and allocation
to exposure are no longer independent (Supplemental Materials B.3.3). Furthermore,
the expectation of the predicted component of CARE is no longer zero because the
probability of exposure is dependent on confounding covariates P(A = a | WC =
wC) 6= P(A = a):
E
[
I(A = 1)
Pˆ(A = 1)
Yˆ
]
− E
[
I(A = 0)
Pˆ(A = 0)
Yˆ
]
=
∑
wC ,yˆ
P(A = 1 | WC = wC)
Pˆ(A = 1)
yˆP(Yˆ = yˆ | WC = wC)P(WC = wC)
−
∑
wC ,yˆ
P(A = 0 | WC = wC)
Pˆ(A = 0)
yˆP(Yˆ = yˆ | WC = wC)P(WC = wC)
6= 0,
where summations generalize to integrals for continuous random variables and the
predictions Yˆ are still independent of the exposure A. This implies that, CARE is
not consistent for the statistical parameter Ψ, even if the covariates WC are sufficient
to control for confounding in the predictions for the outcome Y .
122
Theorem 3: In observational settings, under the strong null hypothesis that there
is no exposure effect for all units, the covariate-adjusted residuals estimator will be
unbiased for the statistical parameter Ψ if the predictions of the outcome are consistent
for the outcome.
Proof : Under the strong null hypothesis, the conditional expectation of the outcome
is the same with or without the allocation to exposure (E(Y | A,WC) = E(Y | WC)).
If the estimates of the outcome Eˆ(Y | W ) are consistent for the outcome Y , as is the
case in linear regression, then the expectation of CARE is zero, which is the statistical
parameter Ψ under the null:
E(ΨˆCARE) = E
(
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(A = 1)
− I(Ai = 0)
Pˆ(A = 0)
)(
Yi − Eˆ(Yi | WCi )
))
= E
(
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(A = 1)
− I(Ai = 0)
Pˆ(A = 0)
))
(Yi − Yi)
= E
(
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(A = 1)
− I(Ai = 0)
Pˆ(A = 0)
))
0
= 0.
B.1.3 CARE–IPW
Theorem 4: The expectation of the covariate-adjusted residuals estimator with
inverse probability weighting (CARE–IPW) is equivalent to the expectation of the
inverse probability of treatment weighting (IPTW) estimator. Thus, CARE–IPW is
consistent for the statistical parameter Ψ in randomized or observational settings.
Proof : The IPTW term of CARE–IPW (3.9) is equivalent to the IPTW estimator
(3.5), which is consistent for Ψ when propensity scores Pˆ(A = 1 | WC) are consistent
for the true conditional probability of exposure P(A = 1 | WC). The expectation of
the predicted term of CARE–IPW is:
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E[
I(A = 1)
Pˆ(A = 1 | WC) Yˆ
]
− E
[
I(A = 0)
1− Pˆ(A = 1 | WC) Yˆ
]
=
∑
wC ,a,yˆ
I(A = 1)yˆP(Yˆ = yˆ | A = a,WC = wC)P(A = a | WC = wC)P(WC = wC)
Pˆ(A = 1 | WC = wC)
−
∑
wC ,a,yˆ
I(A = 0)yˆP(Yˆ = yˆ | A = a,WC = wC)P(A = a | WC = wC)P(WC = wC)
1− Pˆ(A = 1 | WC = wC)
=
∑
wC ,yˆ
yˆP(Yˆ = yˆ | WC = wC)P(WC = wC)−
∑
wC ,y
yˆP(Yˆ = yˆ | WC = wC)P(WC = wC)
= 0,
where the summations generalize to integrals for continuous variables and the predic-
tions Yˆ are independent of the exposure A. Thus, the expectation of CARE-IPW
is equivalent to the expectation of the IPTW estimator and is consistent for the
statistical parameter Ψ, which is consistent for the ATE under the same identifiability
assumptions as for the IPTW estimator.
B.2 CARE–IPW is asymptotically normal
In this Appendix, we discuss the theoretical properties of CARE and CARE–IPW
in randomized trials and observational settings. Before doing so, we first review the
use of augmented inverse probability weighting for estimation and inference of the
G-computation identifiability result in a point-treatment setting.
B.2.1 Review of augmented inverse probability weighting
Suppose our data consist of n independent, identically distributed observations of
O = (WC , A, Y ) where WC are the baseline confounders, A is the exposure, and Y
is the outcome. These data are distributed according to some unknown probability
distribution P, which is an element of a non-parametric or semi-parametric statistical
modelM. Non-parametric statistical models place no restrictions of the set of possible
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observed data distributions, while semi-parametric statistical models place some
restrictions, such as randomization of a binary exposure: P(A = 1 | WC) = 0.5.
We focus on estimation of the G-computation identifiability result (3.2) which
would equal the average treatment effect under the randomization and positivity
assumptions.[162] The efficient influence curve establishes the asymptotic bound for
the variance for all regular, asymptotically linear estimators [14] and is given by the
following for the statistical estimand Ψ(P) = ψ:[165, 76, 196]
D∗(P) =
(
I(A = 1)
P(A = 1 | WC) −
I(A = 0)
P(A = 0 | WC)
)(
Y − E(Y | A,WC))
+ E(Y | A = 1,WC)− E(Y | A = 0,WC)− ψ.
We refer the reader to Kennedy (2017) for an introduction to semi-parametric, efficiency
theory.[103]
The augmented inverse probability of treatment weighting (AIPW) estimator di-
rectly solves the estimating equation corresponding to this efficient influence curve.[165,
196] Specifically, AIPW is the solution in ψ to the estimating equation
0 =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1 | WCi )
− I(Ai = 0)
Pˆ(Ai = 0 | WCi )
)(
Yi − Eˆ(Yi | Ai,WCi )
)
+ Eˆ(Yi | Ai = 1,WCi )− Eˆ(Yi | Ai = 0,WCi )− ψ.
Thus, AIPW requires estimation of both the conditional mean outcome E(Y | A,WC)
and the propensity score P(A = 1 | WC). In most settings, these are unknown
quantities and thus considered nuisance parameters. However, AIPW is double robust
in that it will be consistent for Ψ if either nuisance parameter is consistently estimated.
Under regularity conditions on the nuisance parameter estimation, AIPW is also
asymptotically linear and can be written as an empirical average of a mean-zero, finite-
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variance function of the observed data, called the influence curve, and a remainder
term converging to zero in probability:
AIPW − ψ = 1
n
n∑
i=1
IC(Oi) + oP(1/
√
n)
where E[IC(O)] = 0 and V ar[IC(O)] is finite. Thus, the central limit theorem applies
and AIPW is asymptotically normal. This also provides a straightforward approach
to variance estimation; specifically, we estimate AIPW’s variance with the sample
variance of this estimated influence curve divided by sample size n:
ˆIC
AIPW
=
(
I(Ai = 1)
Pˆ(Ai = 1 | WCi )
− I(Ai = 0)
Pˆ(Ai = 0 | WCi )
)(
Yi − Eˆ(Yi | Ai,WCi )
)
+ Eˆ(Yi | Ai = 1,WCi )− Eˆ(Yi | Ai = 0,WCi )− ψˆ.
Finally, if both nuisance parameters are estimated at fast enough rates, AIPW
is locally efficient in that its influence curve equals the efficient influence curve
(ICAIPW = D∗(P)) and it achieves the smallest possible variance.
B.2.2 Consistency and normality of CARE–IPW
CARE–IPW can be considered a special case of AIPW where the conditional mean
outcome is estimated ignoring the exposure: Eˆ(Y | A,WC) = Eˆ(Y | WC). Thereby,
CARE–IPW is the solution in ψ to the estimating equation:
0 =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1 | WCi )
− I(Ai = 0)
Pˆ(Ai = 0 | WCi )
)(
Yi − Eˆ(Yi | WCi )
)− ψ.
As a result, CARE–IPW inherits many of the properties of AIPW. First, CARE–IPW
will be consistent for Ψ(P) if either the estimated propensity score Pˆ(A = 1 | WC)
converges to the true propensity score P(A = 1 | WC) or if the predicted outcome
in the absence of the exposure Eˆ(Y | WC) converges to the true conditional mean
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outcome E(Y | A,WC). This implies that CARE–IPW is only double robust under
the null when we have E(Y | A,WC) = E(Y | WC). When there is an effect (i.e. when
the null is false), CARE–IPW relies fully on consistent estimation of the propensity
score P(A = 1 | WC). Second, under the same regularity conditions, CARE–IPW is
asymptotically normal, and its variance can be estimated by the sample variance of
the following influence curve divided by sample size n:
ˆIC
CARE−IPW
=
(
I(Ai = 1)
Pˆ(Ai = 1 | WCi )
− I(Ai = 0)
Pˆ(Ai = 0 | WCi )
)(
Yi − Eˆ(Yi | WCi )
)− ψˆ.
Finally, under consistent estimation of both nuisance parameters, which again can
only occur under the null, CARE–IPW is locally efficient. In other settings, we do,
however, expect CARE–IPW to provide efficiency gains over the IPTW estimator,
which is the solution in ψ to the estimating equation
0 =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1 | WCi )
− I(Ai = 0)
Pˆ(Ai = 0 | WCi )
)
Yi − ψ.
Specifically, predicting the outcome with the covariates Eˆ(Y | WC) in CARE–IPW
should result in a more precise estimator than predicting the outcome with zero as
with the IPTW estimator.
B.2.3 Consistency and normality of CARE
CARE is also a special case of AIPW where the propensity score is estimated
ignoring the covariates Pˆ(A = 1) and the conditional mean outcome is estimated
ignoring the exposure Eˆ(Y | A,WC) = Eˆ(Y | WC). In other words, CARE is the
solution in ψ to the estimating equation:
0 =
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1)
− I(Ai = 0)
Pˆ(Ai = 0)
)(
Yi − Eˆ(Yi | WCi )
)− ψ.
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As a result, CARE will be consistent for Ψ(P) only (i) when the conditional mean
outcome is consistently estimated, which can only occur under the null (E(Y |
A,WC) = E(Y | WC)); or (ii) in a randomized trial where the propensity score
is known and always consistently estimated. This implies that in an observational
setting, CARE is not consistent when there is an intervention effect. However, by
controlling for confounders WC when predicting the outcome, CARE is still expected
to be less biased that the unadjusted in observational settings. Second, under the
same regularity conditions, CARE is asymptotically normal, and its variance can be
estimated by the sample variance of the following influence curve divided by sample
size n:
ˆIC
CARE
=
(
I(Ai = 1)
Pˆ(Ai = 1)
− I(Ai = 0)
Pˆ(Ai = 0)
)(
Yi − Eˆ(Yi | WCi )
)− ψˆ.
Finally, under consistent estimation of both nuisance parameters, which can only
occur under the null and in a trial setting, CARE will be locally efficient. In trial
setting, however, we do expect CARE to provide efficiency gains over the unadjusted
estimator from covariate adjustment when predicting the outcome Eˆ(Y | WC).
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B.3 Supplementary Materials
B.3.1 Diagrams including unmeasured covariates
a)
A Y
WY
UWY
UYUA
b)
A Y
WC
WA WY
UWYUWA
UWC
UA UY
Figure B.1. Causal diagrams for randomized trials (a) and observational studies
(b) including measured and unmeasured covariates. These diagrams give us a visual
representation of the relationships between the variables in a causal model. Arrows
are drawn from a cause to an effect; dashed double-sided arrows indicate an unknown
or unmeasured relationship. In a randomized setting, the exposure of interest (A) is
independent of all other variables and the outcome of interest (Y ) is influenced by
both A and a set of other covariates (W Y ). Randomization also guarantees that the
unmeasured factors influencing A (UA) are independent of the unmeasured factors
influencing W Y (UWY ) and Y (UY ). In an observational setting, A is no longer
randomized, but instead influenced by other covariates. Some of these covariates (WC)
also influence Y , thus confounding the relationship between A and Y . Other covariates
(WA) only influence A and not Y . Without randomization any of the unmeasured
covariates may have a relationship with any of the other unmeasured covariates, as
indicated by the dashed arrows around the perimeter of the diagram.
B.3.2 The unadjusted estimator is consistent for the statistical parameter
ΨRCT in randomized trials
Theorem S1: In randomized trials, due to the absence of confounding covariates,
the unadjusted estimator is consistent for the statistical parameter ΨRCT .
Proof : Starting from (3.4), we can use the fact that na = n × Pˆ(A = a), where
Pˆ(A = a) is the empirical likelihood of assignment to exposure a, to rewrite the
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estimator like so:
Ψˆunadj =
1
n1
∑
i∀Ai=1
Yi − 1
n0
∑
i∀Ai=0
Yi
=
1
n
n∑
i=1
I(Ai = 1)Yi
Pˆ(A = 1)
− 1
n
n∑
i=1
I(Ai = 0)Yi
Pˆ(A = 0)
=
1
n
n∑
i=1
(
I(Ai = 1)
Pˆ(A = 1)
− I(Ai = 0)
Pˆ(A = 0)
)
Yi.
The expected value of the unadjusted estimator is equal to the statistical parameter
ΨRCT (3.3), which identifies the average treatment effect in randomized trials by
design:
E
[
Ψˆunadj
]
= E
[
I(A = 1)
Pˆ(A = 1)
Y
]
− E
[
I(A = 0)
Pˆ(A = 0)
Y
]
=
∑
wY ,a,y
I(A = 1)
Pˆ(A = 1)
yP(Y = y | A = a,W Y = wY )P(A = a | W Y = wY )P(W Y = wY )
−
∑
wY ,a,y
I(A = 0)
Pˆ(A = 0)
yP(Y = y | A = a,W Y = wY )P(A = a | W Y = wY )P(W Y = wY )
=
∑
wY ,y
yP(Y = y | A = 1,W Y = wY )P(W Y = wY )
−
∑
wY ,y
yP(Y = y | A = 0,W Y = wY )P(W Y = wY )
= EWY
[
E(Y | A = 1)− E(Y | A = 0)
]
= E(Y | A = 1)− E(Y | A = 0)
= ΨRCT ,
where summations generalize to integrals for continuous random variables. By sat-
isfying the randomization assumption, P(A = a | W Y = W Y ) = P(A = a) which
cancels with the empirical probability of allocation Pˆ(A = a) for each group. Since
the baseline covariates W Y are independent of the exposure A, their distribution is
asymptotically equivalent between exposure groups.
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B.3.3 The unadjusted estimator is biased for the statistical parameter Ψ
in observational studies
Theorem S2: In observational settings, when there are covariates that influence both
the allocation to exposure and the outcome, the unadjusted estimator is confounded
and is thus biased for the statistical parameter Ψ.
Proof :
E
[
Ψˆunadj
]
= E
[
I(A = 1)
Pˆ(A = 1)
Y
]
− E
[
I(A = 0)
Pˆ(A = 0)
Y
]
=
∑
w,a,y
I(A = 1)
Pˆ(A = 1)
yP(Y = y | A = a,W = w)P(A = a | W = w)P(W = w)
−
∑
w,a,y
I(A = 0)
Pˆ(A = 0)
yP(Y = y | A = a,W = w)P(A = a | W = w)P(W = w)
=
∑
w,y
P(A = 1 | WC = wC)
Pˆ(A = 1)
yP(Y = y | A = 1,W = w)P(W = w)
−
∑
w,y
P(A = 0 | WC = wC)
Pˆ(A = 0)
yP(Y = y | A = 0,W = w)P(W = w)
6= Ψ,
where the set of baseline covariates W contains both the covariates that only influence
the outcome W Y and the confounding covariates WC . In this setting, the conditional
probability of exposure depends on the confounding covariates and is independent
of the other baseline covariates W Y that only affect the outcome P(A = a | W =
w) = P(A = a | WC = WC). Due to this confounding, the conditional probability
of exposure is not offset by the empirical probability of exposure Pˆ(A = 1) as in
randomized settings.
131
B.3.4 The IPTW estimator is consistent for the statistical parameter Ψ
Theorem S3: In randomized or observational settings, the inverse probability weight-
ing estimator is consistent for the statistical parameter Ψ when propensity scores are
consistently estimated.
Proof : The inverse probability of treatment weighting (IPTW) estimator adjusts
for the confounding covariates between the outcome and the allocation to exposure
by replacing the empirical probability of exposure Pˆ(A = 1) with propensity scores
Pˆ(A = 1 | WC = wC). If the propensity scores are consistent for the true conditional
probability of exposure P(A = 1 | WC = wC), the IPTW estimator makes consistent
estimates for the statistical parameter Ψ:
E
[
ΨˆIPTW
]
= E
[
I(A = 1)
Pˆ(A = 1 | WC = wC)Y
]
− E
[
I(A = 0)
1− Pˆ(A = 1 | WC = wC)Y
]
=
∑
w,a,y
I(A = 1)yP(Y = y | A = a,W = w)P(A = a | W = w)P(W = w)
Pˆ(A = 1 | WC = wC)
−
∑
w,a,y
I(A = 0)yP(Y = y | A = a,W = w)P(A = a | W = w)P(W = w)
1− Pˆ(A = 1 | WC = wC)
=
∑
w,a,y
I(A = 1)yP(Y = y | A = a,W = w)P(A = a | WC = wC)P(W = w)
Pˆ(A = 1 | WC = wC)
−
∑
w,a,y
I(A = 0)yP(Y = y | A = a,W = w)P(A = a | WC = wC)P(W = w)
1− Pˆ(A = 1 | WC = wC)
=
∑
w,y
yP(Y = y | A = 1,W = w)P(W = w)−
∑
w,y
yP(Y = y | A = 0,W = w)P(W = w)
= EW
[
E(Y | A = 1)− E(Y | A = 0)
]
= EWC
[
E(Y | A = 1)− E(Y | A = 0)
]
= Ψ.
If there is no unmeasured confounding and the propensity scores are consistent for the
true probability of allocation, then they cancel out each other out. The distribution of
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covariates that only influence the outcome W Y are asymptotically equivalent between
the exposure groups, therefore the expectation only needs to be taken over the
confounding covariates WC . The IPTW estimator is especially sensitive to positivity
violations. The propensity scores must be between zero and one across all values of
WC = wC , otherwise ΨˆIPTW will be undefined. Note that the propensity score is
not required to include the baseline covariates that influence only the allocation to
exposure WA for this estimator to be consistent for Ψ. In fact, including WA in the
estimation of the propensity scores could make predictions for A that are closer to
zero or one, which could destabilize the estimate of the exposure effect.
The statistical parameter Ψ identifies the ATE in randomized and observational
settings under the identifiability assumptions outlined in Section 3.2.
B.3.5 More simulation results
B.3.5.1 Ghana sims
In randomized trials with the estimators restricted to using only average age in
months W1 and percent of children who are female W2, as in the case study, all
estimators had low bias and sufficiently high confidence interval coverage. but CARE
and CARE–IPW had more statistical power and less variance (Table B.1). These
simulations suggest that the CARE and CARE–IPW estimators may add value in the
case study due to their more precise estimates of the exposure effect.
B.3.5.2 Full observational results
When not accounting for the confounding covariate prior childhood mortality W3,
the IPTW estimator had large bias in the observational simulations (Table B.2). When
accounting for the confounding covariate, the IPTW estimator had slightly more bias
but less variability when accounting for non-confounding covariates average age in
months W1 and percent of children that were female W2. The IPTW estimator had
high confidence interval coverage regardless of the covariates it adjusted for.
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Exposure Estimator Bias MC SE Average SE CI coverage
Power/
Type I
error
Effect
CARE–IPW 0.03 4.85 4.71 94.2% 69.6%
CARE 0.28 4.73 4.65 94.4% 69%
IPTW 0.02 4.84 8.91 100% 12.3%
Unadj 0.01 5.35 5.24 94.4% 60.6%
Null
CARE–IPW 0.02 5.01 4.86 94.3% 5.7%
CARE 0.03 4.89 4.80 94.5% 5.5%
IPTW 0.02 5.01 10.01 100% 0%
Unadj 0.01 5.53 5.42 94.4% 5.6%
Table B.1. Simulation results for the effect estimators in randomized trials, with the
regressions for predicting the outcome and estimating the propensity scores restricted
to using W1 and W2 as in the bednets case study.
Exposure P-score Bias MC SE Average SE CI coverage
Power/
Type I
error
Effect
W1+W2 8.63 4.77 8.86 96.7% 0.2%
W1+W2+W3 0.36 5.70 10.23 99.9% 2.7%
W3 0.26 6.10 10.08 99.9% 5.1%
Null
W1+W2 9.35 4.93 10.04 98.3% 1.7%
W1+W2+W3 0.37 5.80 11.21 100% 0%
W3 0.27 6.23 11.05 100% 0%
Table B.2. Simulation results for the IPTW estimator in observational settings across
approaches.
When CARE did not account for the confounding covariate W3, it was biased
with low confidence interval coverage (Table B.3). When there was an exposure effect,
CARE had less bias and more statistical power when it accounted for all covariates
than when it only accounted for the confounding covariate. However, under the null,
CARE had more bias when it accounted for all covariates than when it only accounted
for the confounding covariate.
When CARE–IPW did not account for the confounding covariate W3 in its
propensity score, it had similar results to CARE for each outcome equation (Table
B.4). When CARE–IPW accounted for the confounding covariate in the propensity
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Exposure Outcome Bias MC SE Average SE CI coverage
Power/
Type I
error
Effect
W1+W2 8.69 4.68 4.59 51.7% 11.6%
W1+W2+W3 0.10 4.08 4.20 95.2% 80.6%
W3 1.45 4.36 4.56 94.9% 61.9%
Null
W1+W2 9.14 4.83 4.75 50.6% 49.4%
W1+W2+W3 -1.51 4.04 4.25 95.1% 4.9%
W3 0.13 4.40 4.62 95.8% 4.2%
Table B.3. Simulation results for CARE in observational settings across approaches.
score, with or without the non-confounding covariates, the estimator had low bias and
high confidence interval coverage. When accounting for all of the covariates to predict
the outcome, not including the exposure, the CARE–IPW estimator had the least
average standard error and the most statistical power.
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Exposure Outcome P-score Bias MC SE
Average
SE CI coverage
Power/
Type I
error
Effect
W1+W2 W1+W2 8.62 4.79 4.65 53% 12.1%
W1+W2+W3 W1+W2 -0.19 4.19 4.28 95.3% 81.2%
W3 W1+W2 1.48 3.87 4.63 97% 62.3%
W1+W2 W1+W2+W3 0.23 4.82 5.68 97.2% 54.2%
W1+W2+W3 W1+W2+W3 -0.16 5.02 4.64 94.9% 75.4%
W3 W1+W2+W3 0.05 4.50 5.06 97.5% 67.8%
W1+W2 W3 0.44 4.75 5.57 97.1% 54.5%
W1+W2+W3 W3 0.16 4.93 4.57 94.9% 74.6%
W3 W3 -0.02 5.08 4.98 94.9% 67.3%
Null
W1+W2 W1+W2 9.33 4.95 4.81 49.6% 50.4%
W1+W2+W3 W1+W2 -1.52 4.14 4.31 95% 5%
W3 W1+W2 0.16 3.87 4.70 98% 2%
W1+W2 W1+W2+W3 0.21 4.78 5.52 97.2% 2.8%
W1+W2+W3 W1+W2+W3 -0.16 5.58 4.74 94.4% 5.6%
W3 W1+W2+W3 -0.05 4.69 5.12 97.5% 2.5%
W1+W2 W3 0.18 4.72 5.45 97.2% 2.8%
W1+W2+W3 W3 -0.15 5.28 4.68 94.4% 5.6%
W3 W3 -0.11 5.28 5.03 94.6% 5.4%
Table B.4. Simulation results for CARE–IPW in observational settings across
approaches.
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APPENDIX C
INCORPORATING FORECASTS INTO ESTIMATES OF
THE AVERAGE TREATMENT EFFECT WITH AN
APPLICATION TO ZIKA EMERGENCY OPERATIONS
CENTERS IN THAILAND SUPPLEMENTAL MATERIALS
C.1 Synthetic simulation correlation matrix Σ
Temp Rain DHF
N D J N D J N D J

N 1 0.8 0.6 0.4 0.2 0.1 0.4 0.2 0.1
Temp D 0.8 1 0.8 0.2 0.4 0.2 0.2 0.4 0.2
J 0.6 0.8 1 0.1 0.2 0.4 0.1 0.2 0.4
N 0.4 0.2 0.1 1 0.8 0.6 0.4 0.2 0.1
Rain D 0.2 0.4 0.2 0.8 1 0.8 0.2 0.4 0.2
J 0.1 0.2 0.4 0.6 0.8 1 0.1 0.2 0.4
N 0.4 0.2 0.1 0.4 0.2 0.1 1 0.8 0.6
DHF D 0.2 0.4 0.2 0.2 0.4 0.2 0.8 1 0.8
J 0.1 0.2 0.4 0.1 0.2 0.4 0.6 0.8 1
Table C.1. The correlation matrix Σ used to generate synthetic values of temperature,
rainfall, and dengue hemorrhagic fever (DHF) incidence for November, December, and
January (denoted N , D, and J).
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C.2 Forecasting accuracy and effect estimation
C.2.1 Synthetic simulation
C.2.1.1 IPTW
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Figure C.1. The covariate fit curves showing the associations between the absolute
error in effect estimation with the IPTW(F) estimator and simulation-level covariates
including forecasting relative mean absolute error in the synthetic simulations. Simu-
lations with fewer provinces receiving the exposure, higher DHF incidence amongst
unexposed provinces, and with less forecasting error relative to the baseline had less
estimation error.
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Figure C.2. The covariate fit curves showing the associations between the standard
error of the IPTW(F) estimator and simulation-level covariates including forecasting
relative mean absolute error in the synthetic simulations. Simulations with fewer
provinces receiving the exposure, higher DHF incidence amongst unexposed provinces,
and with less forecasting error relative to the baseline had less estimated standard
error.
C.2.1.2 CARE–IPW
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Figure C.3. The covariate fit curves showing the associations between the absolute
error in effect estimation with the CARE(F,F) estimator and simulation-level covariates
including forecasting relative mean absolute error in the synthetic simulations. After
adjusting for the number of exposed provinces and the unexposed DHF rate, less
forecast relative mean absolute error reduced the error in effect estimation.
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Figure C.4. The covariate fit curves showing the associations between the standard
error of the CARE(F,F) estimator and simulation-level covariates including forecasting
relative mean absolute error in the synthetic simulations. Simulations with higher
DHF incidence amongst unexposed provinces and with less forecasting error relative
to the baseline had less estimated standard error.
C.2.2 Historical simulation
C.2.2.1 IPTW
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Figure C.5. The covariate fit curves showing the associations between the absolute
error in effect estimation with the IPTW(F) estimator and simulation-level covari-
ates including forecasting relative mean absolute error in the historical simulations.
Simulations with lower DHF incidence amongst unexposed provinces and with less
forecasting error relative to the baseline had less error in effect estimates.
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Figure C.6. The covariate fit curves showing the associations between the standard
error of the IPTW(F) estimator and simulation-level covariates including forecasting
relative mean absolute error in the historical simulations. After adjusting for the
number of exposed provinces and the unexposed DHF rate, forecast relative mean
absolute error had a negligible association with estimated standard error.
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Figure C.7. The covariate fit curves showing the associations between the confidence
interval coverage of the IPTW(F) estimator and simulation-level covariates including
forecasting relative mean absolute error in the historical simulations. After adjusting
for the number of exposed provinces and the unexposed DHF rate, less forecast relative
mean absolute error was associated with higher confidence interval coverage.
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C.2.2.2 CARE–IPW
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Figure C.8. The covariate fit curves showing the associations between the absolute
error in effect estimation with the CARE(L,F) estimator with respect to simulation-
level covariates including forecasting relative mean absolute error in the historical
simulations. After adjusting for the number of exposed provinces and the unexposed
DHF rate, less forecast relative mean absolute error was associated slightly less error
in effect estimation.
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Figure C.9. The covariate fit curves showing the associations between the standard
error of the CARE(L,F) estimator and simulation-level covariates including forecasting
relative mean absolute error in the synthetic simulations.
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Figure C.10. The covariate fit curves showing the associations between the confidence
interval coverage of the CARE(L,F) estimator and simulation-level covariates including
forecasting relative mean absolute error in the historical simulations. Confidence
interval coverage had no association with forecasting error after adjusting for the
number of exposed provinces and the unexposed DHF rate.
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